Skip to main content
eLife logoLink to eLife
. 2021 Dec 17;10:e66973. doi: 10.7554/eLife.66973

5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function

Elitsa Stoyanova 1, Michael Riad 1, Anjana Rao 2,3,4, Nathaniel Heintz 1,
Editors: Anne E West5, Catherine Dulac6
PMCID: PMC8683082  PMID: 34919053

Abstract

Although high levels of 5-hydroxymethylcytosine (5hmC) accumulate in mammalian neurons, our knowledge of its roles in terminal differentiation or as an intermediate in active DNA demethylation is incomplete. We report high-resolution mapping of DNA methylation and hydroxymethylation, chromatin accessibility, and histone marks in developing postmitotic Purkinje cells (PCs) in Mus musculus. Our data reveal new relationships between PC transcriptional and epigenetic programs, and identify a class of genes that lose both 5-methylcytosine (5mC) and 5hmC during terminal differentiation. Deletion of the 5hmC writers Tet1, Tet2, and Tet3 from postmitotic PCs prevents loss of 5mC and 5hmC in regulatory domains and gene bodies, and hinders transcriptional and epigenetic developmental transitions. Our data demonstrate that Tet-mediated active DNA demethylation occurs in vivo, and that acquisition of the precise molecular properties of adult PCs require continued oxidation of 5mC to 5hmC during the final phases of differentiation.

Research organism: Mouse

eLife digest

At birth, the mammalian brain contains tens of billions of neurons. Although the number does not increase much as the animal grows, there are many dramatic changes to their size and structure. These changes allow the neurons to communicate with one another, develop into networks, and learn the tasks of the adult brain. One way that these changes occur is by the accumulation of chemical marks on each neuron’s DNA that help dictate which genes switch on, and which turn off.

One of the most common ways that DNA can be marked is through the addition of a chemical group called a methyl group to one of the four DNA bases, cytosine. This process is called methylation. When methylation occurs, cytosine becomes 5-methylcytosine, or 5mC for short.

In 2009, researchers found another modification present in the DNA in the brain: 5-hydroxymethylcytosine, or 5hmC. This modification appears when a group of proteins called the Tet hydroxylases turn 5mC into 5hmC. Converting 5mC to 5hmC normally helps cells remove marks on their DNA before they divide and expand. This is important because the newly generated cells need to be able to accumulate their own methylation marks to perform their roles properly. However, neurons in the brain accumulate 5hmC after birth, when the cells are no longer dividing, indicating that 5hmC may be required for the neurons to mature.

Stoyanova et al. set out to determine whether mouse neurons need 5hmC to get their adult characteristics by tracking the chemical changes that occur in DNA from birth to adulthood. Some of the mice they tested produced 5hmC normally, while others lacked the genes necessary to make the Tet proteins in a specific class of neurons, preventing them from converting 5mC to 5hmC as they differentiate. The results reveal that neurons do not mature properly if 5hmC is not produced continuously following the first week of life. This is because neurons need to have the right genes switched on and off to differentiate correctly, and this only happens when 5hmC accumulates in some genes, while 5hmC and 5mC are removed from others. The data highlight the role of the Tet proteins, which convert 5mC into 5hmC, in preparing the marks for removal and demonstrate that active removal of these marks is essential for neuronal differentiation.

Given the role of 5hmC in the development of neurons, it is possible that problems in this system could contribute to brain disorders. Further studies aimed at understanding how cells control 5hmC levels could lead to new ways to improve brain health. Research has also shown that if dividing cells lose the ability to make 5hmC, they can become cancerous. Future work could explain more about how and why this happens.

Introduction

Development of the mammalian brain requires generation of hundreds of millions of neuronal progenitors that differentiate into distinct cell types with refined functional properties. Although morphological and physiological maturation of most neurons occurs between mid-gestation and a few months or years after birth, the vast majority of CNS neurons must maintain a stable differentiated state for the life of the organism and remain sufficiently plastic to participate in novel behaviors. Studies of signaling molecules and transcriptional programs have identified many mechanisms that orchestrate critical steps in neurogenesis, cell type diversification, neuronal migration, axonal pathfinding, and differentiation. Although it has been established that epigenetic regulatory mechanisms are critical for proper development of all cell types, our knowledge of the precise roles of these mechanisms in neuronal differentiation, function, and vitality remains rudimentary.

5-Hydroxymethylcytosine (5hmC) is produced from 5-methylcytosine (5mC) by the Ten-eleven translocation dioxygenases (Tet1, Tet2, Tet3) (Iyer et al., 2009; Tahiliani et al., 2009). It is present at approximately 10-fold higher levels in neurons than peripheral cell types (Globisch et al., 2010; Kriaucionis and Heintz, 2009), and its distribution across the genome of adult neurons is cell specific and correlated with active gene expression (Mellén et al., 2017; Mellén et al., 2012; Szulwach et al., 2011). The initial discovery that 5hmC accumulates within active gene bodies, coupled with the discovery that MeCP2 can bind probes containing 5hmC with high affinity, led to the proposal that MeCP2 binding within active genes facilitates their expression (Mellén et al., 2012). Further studies demonstrating that MeCP2 binds 5hmC at high affinity in non-CG dinucleotides but does not bind to 5hmCG overturned this model (Ayata, 2013; Gabel et al., 2015; Mellén et al., 2017) by revealing that accumulation of 5hmCG and the depletion of 5hmCH in gene bodies is correlated with less MeCP2 binding and increased expression (Ayata, 2013; Gabel et al., 2015; Mellén et al., 2017). Imaging of the binding and diffusion of single MeCP2 molecules in living neurons lacking Dnmt3a or Tet1, Tet2, and Tet3 demonstrate that its binding is exquisitely sensitive to the levels of both 5mC and 5hmC (Piccolo et al., 2019). Given these data and the sensitivity of neuronal function to MeCP2 gene dosage (Chahrour et al., 2008; Nan and Bird, 2001), relief of the repressive functions of MeCP2 through Tet-mediated conversion of high-affinity 5mCG-binding sites to low-affinity 5hmCG sites, which we have referred to as functional demethylation (Mellén et al., 2017), provides an important mechanism for modulation of chromatin structure and transcription.

In dividing cells, 5hmC serves as an intermediate in DNA demethylation because maintenance DNA methyltransferases do not recognize hemi-hydroxymethylated cytosines in order to reestablish methylation (Wu and Zhang, 2017). Consequently, 5hmC is lost passively and replaced by C due to replicative dilution. Loss of function studies in mouse embryonic stem cells (ESCs) (Dawlaty et al., 2013) and lymphocyte lineages Lio and Rao, 2019 have demonstrated that the role of Tet-mediated replicative DNA demethylation is to provide full accessibility to regulatory regions necessary for expression of genes required for differentiation. For example, at the activation-induced deaminase (AID) locus in B cells, Tet activity is required for demethylation and activation of enhancer regions that modulate AID expression to enable class switch recombination (Lio et al., 2019). Tet-mediated replication-dependent passive demethylation is thought to be common in many dividing cell types, including progenitor cells in the developing nervous system (MacArthur and Dawlaty, 2021).

Most neurons exit the cell cycle during mid-gestation and remain relatively simple and undifferentiated until birth. Following parturition, they initiate an elaborate program of differentiation that includes dramatic increases in size, morphological complexity, and connectivity. Since these neurons are postmitotic and remain so throughout life, removal of the repressive effects of 5mC by passive demethylation cannot occur. However, in addition to functional demethylation and passive demethylation, a third pathway for DNA demethylation, often referred to as active demethylation, has been proposed based on the finding that 5hmC can be further oxidized by Tet proteins to produce 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). Removal of 5fC and 5caC by thymine DNA glycosylase (TDG)-dependent base excision repair (BER) provides another mechanism for 5hmC-mediated DNA demethylation (He et al., 2011). Clear evidence that this pathway can operate in cultured cells has been presented, and detailed biochemical studies have delineated the mechanisms operating in TDG-BER DNA demethylation (Weber et al., 2016). Active DNA demethylation is ideally suited for remodeling DNA methylation in postmitotic neurons.

Evidence that continued accumulation of 5hmC is required in differentiating neurons and that it can participate in active demethylation in vivo is beginning to emerge. In studies of cerebellar granule cell development in ESC-derived GC cultures, primary GC cultures, and slice preparations, manipulations of Tet activity and 5hmC levels provide strong evidence that 5hmC is required for expression of axon guidance and ion channel genes, and that proper development of the GC dendritic arbor requires 5hmC (Zhu et al., 2016). Demethylation of 5hmC-GFP transfected DNA fragments retrieved after several days in culture display reduced 5hmC levels at several sites as assessed by bisulfite sequencing (BSSeq) in HEK 293 cells and primary hippocampal neurons (Guo et al., 2011). Changes in methylation levels at GGCC sites in the genome of hippocampal dentate gyrus neurons in response to electroconvulsive shock have been documented using the methylation-sensitive cut counting method that employs the methylation or hydroxymethylation-sensitive restriction enzyme HpaII and its methylation-insensitive isoschizomer Msp1 (Guo et al., 2011). Global measurements of 5mC and 5hmC by mass spectroscopy in the hippocampus have shown that both decrease in response to the induction of seizure (Kaas et al., 2013). And in germline Tet1 knockout mice, analysis of the Npas4 and c-Fos promoters has shown that Tet1 is required for their proper regulation in both the cerebral cortex and hippocampus (Rudenko et al., 2013). Despite these observations, our knowledge of the roles of continued 5hmC accumulation in active DNA demethylation and postmitotic differentiation remains rudimentary.

We report here single nucleotide resolution studies of DNA methylation and hydroxymethylation, transcription, chromatin accessibility, and H3K4me3 and H3K27me3 histone marks in postmitotic, differentiating Purkinje cells (PCs). As PCs transition from relatively small, multipolar immature cells to fully elaborated large neurons with complex dendritic arbors and hundreds of thousands of synapses (McKay and Turner, 2005), 5hmC continues to accumulate, and DNA methylation and hydroxymethylation are reconfigured as epigenetic and transcriptional programs progress. Our data confirm previous studies of the relationships between transcription, DNA methylation, DNA hydroxymethylation, and chromatin organization (Lister et al., 2013; Mellén et al., 2017; Tsagaratou et al., 2017; Tsagaratou et al., 2014), and they reveal several novel modes of transcriptional activation and repression. Notably, we identify a class of developmentally induced PC-specific genes that are highly expressed and lose both 5mC and 5hmC in the final stages of PC differentiation.

We report also studies of newly generated Tet1, Tet2, Tet3 PC-specific triple knockout (Pcp2TetTKO) mouse lines in which recombination is activated in the first postnatal week. These data demonstrate that postmitotic transcriptional and epigenetic maturation in PCs, including transcription of many ion channels and active demethylation of late expressed genes, requires continued oxidation of 5mC to 5hmC. Taken together, our data demonstrate that active demethylation occurs in select genes in postmitotic neurons, and that 5hmC plays an essential role in refining the transcriptional and epigenetic status of PCs during the final stages of differentiation.

Results

In mice, PC progenitors complete their final cell cycle between e10.5 and e13.5 within the ventricular zone of the developing cerebellar anlage (Leto et al., 2016). As they exit cell cycle and commit to a PC fate, they express the transcription factors Lhx1/Lhx5 (Chizhikov et al., 2006; Morales and Hatten, 2006). To characterize 5hmC accumulation, transcription and chromatin organization during their postmitotic development, we chose to analyze PCs at the start of their accelerated differentiation (P0), during their rapid phase of morphological development (P7) and as fully mature, differentiated neurons (adult) (Figure 1A–B). We employed fluorescence-activated nuclear sorting (FANS) to purify Itpr1-positive PC nuclei in two biological replicates (Figure 1C–E, Figure S1A) (Xu et al., 2018). Since PCs are extremely rare and difficult to isolate, we optimized low input protocols for genomic profiling. We used ~20,000 nuclei for transcriptional profiling, ~200,000 nuclei for BSSeq and oxidative bisulfite sequencing (OxBSSeq), 25,000 nuclei for the assay for transposase-accessible chromatin sequencing (ATACSeq), and 25,000 nuclei for H3K27me3 and H3K4me3 chromatin immunoprecipitation sequencing (ChIPSeq) (Figure 1E–F). Analysis of biological replicates for each of the assays revealed that the sorted nuclei expressed markers of Purkinje neurons, and did not express genes marking the two most abundant cerebellar cell types, granule cells and glia (Figure S1B). The Pearson correlation coefficients between each replicate at all timepoints and techniques (RNASeq, OxBSSeq, ATACSeq, and ChIPSeq) were high (over 0.9), establishing that our data are reproducible and of very high quality (Figure 1—figure supplement 1C-F). Bisulfite conversion and oxidation rates for the OxBSSeq datasets were within the expected range (Figure 1—figure supplement 1G).

Figure 1. Chromatin landscape in differentiating Purkinje neurons.

(A) Schematic of Purkinje cell (PC) differentiation and growth at P0, P7, and adult (approximately 8-week-old) timepoints. EGL – external granule layer, PCL – Purkinje cell layer, IGL – internal granule layer, MCL – molecular cell layer, GCL – granule cell layer. (B) Immunofluorescence staining with Calb1 (green) of PCs in murine cerebella at P0, P7, and adult timepoints. (C) Example of PC nuclei stained with Itpr1 (green) post-dissociation and pre-sorting, counterstained with DAPI. (D) Representative plots of fluorescence-activated nuclear sorting of PCs at P0, P7, and adult timepoints with Itpr1. (E) Workflow schematic of nuclei isolation, antibody staining with anti-Itpr1, fluorescence-activated sorting, and downstream sequencing applications. (D) Integrated genome viewer (IGV) representation of example regions of differentially regulated genes (Olfr cluster – always silent, Cacnb4 – always expressed, Grid1 and Pde1c – developmentally down-regulated, Atp2a3 and Cep76 – developmentally up-regulated). Top tracks show RNA expression in RPKM (reads per kilobase per million mapped reads), mCG tracks show methylation level in CG context from 0 to 0.8, hmCG tracks show hydroxymethylation level in CG context from 0 to 0.45, mCH and hmCH show methylation and hydroxymethylation level in CH context (H = A, C, or T) from 0 to 0.04. ATAC tracks show ATACSeq read density in RPKM from 0 to 10. H3K4me3 tracks show input normalized enrichment in RPKM from 0 to 5. H3K27me3 tracks show input normalized enrichment in RPKM from 0 to 3.

Figure 1.

Figure 1—figure supplement 1. Quality control of sequencing datasets.

Figure 1—figure supplement 1.

(A) Immunofluorescence staining of Purkinje cells at P0, P7, and adult timepoints with Calb1 (green) and Itpr1 (red). (B) Integrated genome viewer (IGV) representation of Purkinje-specific markers (Itpr1, Calb1, Car8, Kcnip1, Kcnma1, Pcp2) enrichment and depletion of granule (Gabra6, Etv1, Cbln1, Neurod1, Atp2b1, Kcnd2) and glial (Gfap, Sorcs3, Aldh1l1, Olig2) markers. (C) Pearson correlation of RNASeq datasets. (D) Pearson correlation of gene body accumulation of 5hmCG + 5 mCG (bisulfite sequencing [BSSeq]), 5hmCG, and 5mCG (derived from maximum likelihood estimator model of BSSeq and oxidative bisulfite sequencing [OxBSSeq]). (E) Pearson correlation of assay for transposase-accessible chromatin sequencing (ATACSeq), H3K4me3, and H3K27me3 chromatin immunoprecipitation sequencing (ChIPSeq) dataset enrichment ±5 kb around the gene promoters. (F) Pearson correlation of gene body accumulation of 5hmCH and 5mCH (derived from maximum likelihood estimator model of BSSeq and OxBSeq). (G) Bisulfite conversion and oxidation efficiency in BSSeq and OxBSSeq datasets. (H) IGV representation of BSSeq (showing 5hmCG + 5 mCG signal together) and OxBSSeq (showing 5hmCG + 5 mCG signal separately) at the three developmental timepoints.

It is important to note that we chose to focus on OxBSSeq (Booth et al., 2013) as a definitive technology for analysis of DNA methylation because, in contrast to BSSeq alone, it allows us to assess the contributions of both 5mC and 5hmC to neuronal development. Given the distinct functions of these two modifications, analysis of their separate contributions to epigenetic regulation of the genome is more informative than BSSeq alone. For example, in many genes, 5mCG is depleted and 5hmCG accumulates in the gene body as its expression increases between P0 and adult. This is clearly evident for the gene encoding the cyclic GMP-dependent protein kinase (Prkg1), whose expression in PCs has been shown to be essential for long-term depression (Feil et al., 2003). In this case, the OxBSSeq data reveal a transition from 5mCG to 5hmCG that cannot be detected in the BSSeq data as the gene is activated between P0 and adult (Figure 1—figure supplement 1H). These data illustrate that a precise evaluation of DNA methylation status in relation to other programs unfolding during development for this gene and many others is advanced significantly by inclusion of OxBSSeq data.

Transcriptional programs altered during PC differentiation

PC progenitors complete their final divisions in the cerebellar primordium between e11 and e13 (Butts et al., 2014) and remain as a multilayered, simple migrating cell population until birth (P0). In the first postnatal week, they organize into a monolayer as the cerebellum enlarges and begin the transition from a multipolar primitive neuronal morphology to one of the largest neurons in the brain with a characteristic, highly elaborate planar dendritic arbor. As they begin the second postnatal week (P7), PCs undergo an important developmental transition that includes refinement of their climbing fiber input, formation of many thousands of parallel fiber synapses, and myelination of their axons (Leto et al., 2016; McKay and Turner, 2005). The tremendous increase in synaptogenesis and connectivity continues until PCs attain their mature morphology and functions at 3–4 weeks of age. As these programs unfold, there is a global decrease of 5mCG and global increase of 5hmCG (Figure 2—figure supplement 1A).

To identify genes whose transcription is stable and those that are dynamically regulated during PC differentiation, we conducted differential expression analysis between P0 and adult Purkinje neurons, filtering for significance of p < 0.01 and log2 fold change of >2 in either direction (Figure 2A–B, Supplementary file 1). Using these criteria, there were 922 developmentally repressed genes (down-regulated in adult) enriched in categories involved in cell signaling and axon guidance pathways (e.g. Grid1, Pde1c; Figure 1F). We identified 432 genes with increased expression as PCs differentiate encoding proteins known to be important for the mature functions of PCs including calcium ion buffering and transport, regulation of the inositol triphosphate signaling pathway, and RNA splicing. As expected, similar analysis comparing P0 and P7 or P7 and adult data revealed genes overlapping with those identified in the overall P0 and adult comparative data (Figure 2—figure supplement 1B-D), although additional categories of RNA metabolism, synaptic signaling, and ion transport are enriched in the P7 to adult analysis (Figure 2—figure supplement 1C). As anticipated, the P7 profiles we have included in our analysis have been essential in assessing both the developmental course of epigenetic events studied here and the consequences of loss of 5hmC in PCs (see below).

Figure 2. Cytosine modification dynamics in in relation to differential expression and accessibility.

(A) MA plot representing statistically significant (p < 0.01, log2(fold change) > 2) differential gene expression between P0 (blue) and adult (dark gray). Light gray dots represent genes that are not statistically significant. (B) Gene ontology analysis of the developmentally up- and down-regulated genes. (C–E) Metagene plots representing the mean value of 5hmCG/CG, 5mCG/CG (C), assay for transposase-accessible chromatin sequencing (ATACSeq) read density (D) and H3K4me3 accumulation (E) over the gene bodies and promoters of developmentally up- and down-regulated genes over the three timepoints (P0 – blue, P7 – orange, and adult – dark gray). (F) Genome browser representation of the two classes of developmentally down-regulated genes with differential accumulation of CpH modifications. (G–I) Metagene plots representing the mean value of 5hmCH/CH, 5mCH/CH (G), ATACSeq read density (H), and H3K27me3 accumulation (I) over the gene bodies and promoters of developmentally down-regulated genes divided into two clusters by k-means clustering analysis (green for ‘modCHpoor’, purple for ‘modCHrich’). (J) Gene ontology analysis of the two clusters. (K) Genome browser representation of two regions with differential accessibility. (L) Heatmap representing the differentially accessible regions between P0 and adult Purkinje cells (PCs) (p < 0.01, log2(fold change) > 4). (M–N) Metagene plots representing the mean values of 5hmCG/CG and 5mCG/CG (M) and 5hmCH/CH and 5mCH/CH (N) over the centers and flanking regions of peaks that gained or lost accessibility relative to adult PCs.

Figure 2.

Figure 2—figure supplement 1. Gene expression and chromatin dynamics during Purkinje cell (PC) development.

Figure 2—figure supplement 1.

(A). Genome-wide quantification of the levels of 5hmCG and 5mCG at each timepoint. (B) MA plot representing differential gene expression between P7 and adult. Orange shaded dots represent genes enriched in P7 and gray dots represent genes enriched in adult, with absolute log2 fold change of 2 and p-adj value of 0.05. (C) Gene ontology (GO) analysis of differentially expressed genes between P7 and adult. (D) MA plot representing differential gene expression between P0 and P7 timepoints. Blue shaded dots represent genes enriched in P0 and orange dots represent genes enriched in P7, with absolute log2 fold change of 2 and p-adj value of 0.05. (E) Quantification of expression, chromatin accessibility, 5mCG, 5hmCG, H3K4me3, and H3K27me3. (F) Violin plots of the quantifications of 5hmCH, 5mCH, ATAC, and H3K27me3 density over the two clusters of repressed genes. (G) Expression levels log2(TPM + 1) of the genes in each cluster. (H) Differentially abundant motifs of transcription factors in chromatin accessibility data between P0 and adult PCs.

Constitutively expressed genes are epigenetically stable

Despite the many genes that are dynamically regulated during these developmental transitions, the majority of genes in PCs are either silent or constitutively expressed. Approximately half of the genes in the mouse genome (e.g. genes encoding olfactory receptors (Figure 1F), immunoglobulins, hemoglobin subunits, etc.) are never expressed in PCs and remain heavily methylated and inaccessible. As previously reported for other neurons (Mo et al., 2015), there is a second class of silent genes in PCs that are enriched in transcription factors expressed in very early embryos (Hox clusters, other homeobox genes, etc.). These are completely demethylated and enriched for the H3K27me3 histone mark, indicating that they are repressed by the polycomb repressive complex (Li et al., 2018).

Actively transcribed genes whose levels vary little during PC differentiation, for example the calcium channel auxiliary subunit Cacnb4 (Figure 1F), are also epigenetically stable. This is a large (~3000) and diverse class of genes that carry activating epigenetic marks that have been previously characterized: low levels of 5mCG, 5mCH, and 5hmCH; elevated levels of 5hmCG; they are ATAC accessible; and their promoters carry the activating histone mark H3K4me3. As expected, the levels of these marks vary widely between genes and generally reflect the level of expression. As PCs mature, the conversion of 5mC to 5hmC continues to increase within the gene bodies of the most active constitutively expressed genes without a strong impact on expression (Figure 2—figure supplement 1E).

Epigenetic signatures reveal two classes of developmentally repressed genes in PC

To identify mechanisms associated with developmental repression, we analyzed features previously associated negatively with transcription in the 922 genes whose expression decreases during PC differentiation. A consistent finding is that in most genes decreased expression is associated with a loss of promoter accessibility as assayed by assay for transposase-accessible chromatin sequencing (ATACSeq) (Figure 2D and K–L, Figure 2—figure supplement 1E). These changes are not correlated with changes in DNA methylation or H3K27me3 occupancy (Figure 2C, Figure 2—figure supplement 1E). Furthermore, 5hmCG accumulated over the genes bodies early in development is stable or continues to increase (Figure 2C), suggesting that the presence of 5hmCG is not sufficient to maintain transcription. Interestingly, analysis of the repressive marks 5mCH and 5hmCH reveals at least two distinctly recognizable epigenetic patterns in genes that become repressed in PC development (Figure 2F–J, Figure 2—figure supplement 1F-G). Repressed genes that accumulate 5mCH and 5hmCH over their gene bodies (referred to as ‘highCHmod’ genes) are associated with lower promoter accessibility (Figure 2I) and enhanced accumulation (Figure 2H) of H3K27me3 relative to those repressed genes with low levels of CH modification (referred to as ‘lowCHmod’ genes) (Figure 2F–J, Figure 2—figure supplement 1F-G). Gene ontology (GO) analysis indicates that both sets of genes that are repressed as PC differentiation proceeds are associated with development, and that the genes that do not accumulate 5mCH and 5hmCH encode preferentially proteins related to cell morphogenesis and axonal projection (Figure 2J). Although the data for highCHmod genes is consistent with transcriptional inhibition through both polycomb repressive complexes (Li et al., 2018) and MeCP2 binding (Gabel et al., 2015), our data do not identify the mechanisms responsible for repression of the lowCHmod gene class that fail to accumulate repressive CH marks over the gene body as they mature. To discover the mode of repression for these genes will require close examination of intergenic regulatory domains and associated transcriptional repressors and epigenetic marks.

Developmentally activated PC expressed genes

We identified 432 genes that increase in expression as PCs differentiate (Figure 2A, Supplementary file 1). In general, these genes encode proteins known to be important for the mature functions of PCs, including calcium ion buffering and transport, regulation of the inositol triphosphate signaling pathway, and RNA splicing (Figure 2B). The chromatin landscape of most genes whose expression increases during PC differentiation is similar to those that are constitutively transcribed (e.g. Atp2a3, Cep76; Figure 1G). Their promoters are highly accessible (Figure 2D and K–L), they have high levels of H3K4me3 (Figure 2E), their gene bodies have low levels of 5mCG and elevated levels of 5hmCG (Figure 2C), and they do not accumulate 5mCH or 5hmCH (Figure 2N).

Loss of 5mC and 5hmC in active genes during PC differentiation

Our data reveal additional, surprising features that have not been documented in postmitotic cells. Thus, in a small subset of highly expressed genes (e.g. Cep76, Itpr1, Mtss1) there is a profound loss of both 5hmCG and 5mCG during the terminal, postmitotic stage of PC differentiation (Figures 1F and 3). To investigate the apparent demethylation over this class of genes, we computationally identified DNA methylation valleys (DMVs) as previously described (Jeong et al., 2014; Mo et al., 2015; Xie et al., 2013). In brief, DMVs were characterized by filtering undermethylated regions (UMRs) for length (>5 kb) and merging any regions within 1 kb (Burger et al., 2013; Figure 3—figure supplement 1A-B, Supplementary file 2). This revealed multiple regions longer than 15 kb, an unusual finding given that the average length of DMVs is ~5 kb (Figure 3—figure supplement 1D-E; Jeong et al., 2014). As expected from previous studies, a small number of these genes are inactive, fully demethylated, inaccessible, and covered by high levels of H3K27me3 repressive marks (Figure 3A, Foxd1, Figure 3—figure supplement 1C). These genes acquire their characteristics early in development, and their epigenetic features are stable.

Figure 3. Loss of 5mCG and 5hmCG in a novel class of epigenetically regulated highly expressed Purkinje-specific genes.

(A) Integrated genome viewer (IGV) representation of example regions of inactive DNA methylation valley (DMV) (Foxd1) and active Purkinje cell (PC)-specific DMVs (Itpr1, Mtss1). Bisulfite sequencing (BSSeq) tracks shows combined levels of mCG and hmCG ranging from 0 to 1. Bars under BSSeq tracks are computationally identified DMVs, black bars denote hypo-DMRs (differentially methylated regions) in adult, compared to P0 or P7. Bars under assay for transposase-accessible chromatin sequencing (ATACSeq), H3K4me3, and H3K27me3 tracks denote broad peaks of signal enrichment. (B–E) 5hmCG/CG (B), 5mCG/CG (C), ATACSeq log2(read density) RPKM enrichment (D) and H3K4me3 log2(input normalized) RPKM enrichment (E) quantification over DMVs at each timepoint. Boxplots show mean value per DMVs, the test for significance is Wilcoxon. Metagene plots show mean value ±2 kb around the DMV region, regardless of gene directionality. Heatmaps show data summarized in the metagene plots.

Figure 3.

Figure 3—figure supplement 1. Characterization of Purkinje-specific DNA methylation valleys (DMVs).

Figure 3—figure supplement 1.

(A) Schematic of DMV identification and filtering. (B) Distribution of distances between DMVs. DMVs within 1 kb of each other are assumed to be part of the same regulatory region and therefore merged. (C) Assay for transposase-accessible chromatin sequencing (ATACSeq) read density over DMVs shows a bimodal distribution, segregating DMVs into accessible and inaccessible (left panel). Inaccessible DMVs show enrichment for H3K27me3 reads, while accessible DMVs show enrichment for H3K4me3 reads (right panel, dotted and straight lines designate replicates). (D) Distribution of lengths of accessible and inaccessible DMVs. (E) Length of broad peaks of ATACSeq and H3K4me3 chromatin immunoprecipitation sequencing (ChIPSeq) overlapping large accessible DMVs. (F) Expression of the top 500 most expressed genes in Purkinje cells (PCs) and the genes associated with DMVs. (G) DMVs do not accumulate any modifications in CH context. (H). Genes associated with DMVs, red star denotes role in autism, gray in ataxia (I). Cumulative length of DMVs per gene. (J–K) Change of DMV length between P0 and adult (J) and P7 and adult (K). (L) Mass spectrometry analysis of genomic DNA from adult PCs.

The majority of very large DMVs in PCs, however, arise during differentiation through loss of 5mC and 5hmC over active, highly expressed genes as PCs mature (Figure 3, Itpr1, Mtss1). In these genes, the timing of changes in DNA methylation, chromatin accessibility, and dynamic histone marks varies from gene to gene, but the overall progression of events associated with their expression is similar (Figure 3). At birth, these genes are actively transcribed (Figure 3A), 5hmCG is enriched in the gene body (Figure 3B) and 5mCG is depleted (Figure 3C), their promoters are accessible (Figure 3D), and H3K4me3 is present over their promoters (Figure 3E). These epigenetic properties resemble moderately expressed genes in many cell types. As differentiation proceeds and transcription increases, there is a gradual decrease in both 5mCG, 5hmCG, and H3K27me3 histone marks, and ATAC accessibility and H4K4me3 marks spread from the promoter into the gene body. To further support these data, we have included analysis of independent BSSeq experiments that detect the combined levels of 5mC and 5hmC (Figure 3A, BSSeq). These data also reveal that hypo-DMRs (differentially methylated regions) present at P0 expand and fuse as PCs lose both methylation and hydroxymethylation to form the very large DMRs that are characteristics of these genes (Figure 3A, hypo-DMR track). As shown in Figure 3B–E and Figure 3—figure supplement 1I-K, quantitation of these features demonstrates that that loss of DNA methylation and hydroxymethylation occurs over the entire gene body for these genes as H3K4me3 activating histone marks accumulate and ATAC accessibility increases.

Interestingly, many of the active genes associated with broad DMVs are PC-specific and highly expressed (Figure 3—figure supplement 1F). GO analysis indicates that they are involved in the inositol triphosphate/calcium signaling pathways, and a subset is associated with ataxia and autism (Figure 3—figure supplement 1H). They do not accumulate modified cytosines in CpH context (Figure 3—figure supplement 1G). These data provide strong evidence that DNA demethylation can occur in postmitotic neurons, and that it is enhanced in a specific class of genes that are very highly expressed and functionally important. Although our mass spectroscopic analysis of genomic DNA from differentiating PCs (Figure 3—figure supplement 1L) failed to detect 5fC or 5caC, their involvement as transient intermediates in the loss of 5mC and 5hmC cannot be ruled out because the small fraction of the genome covered by this gene class may preclude their detection (Guo et al., 2011; He et al., 2011; Ito et al., 2011).

Loss of 5mC and 5hmC in putative regulatory sites during PC differentiation

Previous studies of enhancers and other regulatory sites have established that their activation is accompanied by increased ATAC accessibility and loss of DNA methylation (Lio et al., 2016). To determine whether loss of DNA methylation can occur in putative regulatory sites in addition to large DMRs in postmitotic PCs, we used an established computational method (Burger et al., 2013) to identify small regions with statistically significant ATACSeq signal enrichment (Figure 2K–N). We then employed differential accessibility analysis to divide those regions into two groups based the magnitude (log2 fold change >4) and significance (p < 0.01) of their changes during PC differentiation. Those that became more accessible between P0 and adult (log2 fold change >4) experienced a ‘gain’ and those whose accessibility diminished during this time are characterized by a ‘loss’. As anticipated, those ATAC peaks that gain accessibility lose both 5hmC and 5mC as cells progress from P0 to adult (Figure 2N, Gain section) whereas no significant changes in methylation at ATAC peak centers occur in sites that lose accessibility (Figure 2N, Loss section). Although these ATAC peaks have not been identified as active enhancers, it is noteworthy that the transcription factor motifs found in these different classes of ATAC sites are distinct (Figure 2—figure supplement 1H). These findings are consistent with prior studies indicating that enhancer activation is accompanied by enhanced ATAC accessibility and DNA demethylation (Lio et al., 2016). In this case, however, DNA demethylation does not require cell division.

PC-specific Tet1, Tet2, Tet3 triple knockout mouse lines

Despite convincing evidence that Tet-mediated active DNA demethylation can occur in mouse ESCs through the TDG-BER pathway (He et al., 2011; Weber et al., 2016), evidence that this can occur in vivo has been difficult to obtain because such a proof requires loss or complete inhibition of all three Tet oxidases in a single cell type after cells have exited the cell cycle permanently. To provide this evidence, we generated PC-specific Tet1/Tet2/Tet3 triple knockout (Pcp2TetTKO) mouse lines (Figure 4A). We chose to drive Cre recombinase expression using an engineered Pcp2 BAC employed previously to generate accurate Cre driver lines (Gong et al., 2007) because the onset of expression of the Pcp2 gene and the corresponding BAC vector occurs approximately 1 week after birth as the cerebellum enters its terminal phase of development and maturation. The Pcp2Cre BAC was introduced by pronuclear injection into ova from females carrying floxed alleles of all three Tet genes (Figure 4—figure supplement 1A-B) yielding several founder lines. PCR analysis of the floxed regions of each Tet gene in purified PC genomic DNA, and RNASeq analysis confirmed the deletion of exons from all three TET proteins (Figure 4—figure supplement 1C-D). The lines chosen for analysis displayed no gross motor phenotype as assessed by rotarod performance, survival was normal, and recombination activity was specific to PCs (Figure 4B–D, Figure 4—figure supplement 2A-D). The deletion of the Tet proteins did not affect the expression of Itpr1 significantly, and we confirmed that it could still be used for purification of PCs (Figure 4—figure supplement 1E-F). Evaluation of the quality control metrics of the datasets showed strong correlation coefficients and enrichment for Purkinje markers (Figure 4—figure supplement 1G-H). Cre recombinase activity, and thus recombination in the Tet genes, began at approximately P7 more than 2 weeks after PCs have completed their last division (Figure 4—figure supplement 2A-D). These lines, therefore, allow assessment of the consequences of loss of Tet activity during the rapid phase of somatic and dendritic growth in postmitotic, differentiating Purkinje neurons.

Figure 4. Loss of Tet activity leads to impaired gene expression regulation in Purkinje cells (PCs).

(A) Schematic of experimental design to probe the triple Tet1, Tet2, Tet3 knockout effect in adult PCs. (B) Kaplan-Meier curve representing the survival fraction of wild-type (WT) (n = 8) and PC-specific triple knockout (Pcp2TetTKO) (Founder13 n = 8, Founder19 n = 8) mice since date of birth. (C) Body weight of WT and Pcp2TetTKO at 8 weeks. (D) Rotarod evaluation of motor skills in WT and Pcp2TetTKO at 8 weeks. (E) MA plot representing differential gene expression analysis between WT and Pcp2TetTKO. Navy dots represent genes with p-value < 0.05, red dots – ion channels. (F) Gene ontology analysis of statistically significant differentially expressed genes. Top panel shows categories of genes with increased expression in Pcp2TetTKO, bottom panel shows genes with decreased expression in Pcp2TetTKO. (G) Levels of 5hmCG/CG and 5mCG/CG over differentially accessible peaks only present in adult PCs (compared to P0). (H) Integrated genome viewer (IGV) representation of example DNA methylation valleys (DMVs) affected by Pcp2TetTKO. Hox cluster and Calb1 show minor changes in length as they are established before the P7 onset of Cre. Gpr63 and Grid2 show significant reduction in length as they are established after P7. Solid bars represent DMVs identified at each condition. (I) Quantification of 5hmCG/CG and 5mCG/CG over the two classes of DMVs – Hox cluster and large active DMVs.

Figure 4.

Figure 4—figure supplement 1. Generation of Pcp2 cre/wt:: Tet1 del/del:: Tet2 del/del:: Tet3 del/del (Purkinje cell-specific triple knockout [Pcp2TetTKO]) mouse founder lines.

Figure 4—figure supplement 1.

(A) Expression levels of Tet1, Tet2, and Tet3 proteins at P0, P7, and adult developmental stages of Purkinje cells. (B) Schematic of Pcp2TetTKO generation via pronuclear injection. (C) PCR genotyping for CRE, Tet1 deletion, Tet2 deletion, and Tet3 deletion in adult Pcp2TetTKO Purkinje genomic DNA. (D) Deletion of Tet2 exons evident in nuclear RNASeq Pcp2TetTKO. (E) Example of Pcp2TetTKO nuclei stained with Itpr1 post-dissociation and pre-sorting, counterstained with DAPI, a heterochromatin marker. (F) Example fluorescence-activated nuclear sorting (FANS) plot of adult Pcp2TetTKO nuclei. (G) Pearson correlation between TKO and control. (H) Integrated genome viewer (IGV) representation of Purkinje-specific markers (Itpr1, Calb1, Car8, Kitl, Kcnip1, Kcnma1, Pcp2) enrichment and depletion of granule (Gabra6, Etv1, Cbln1, Neurod1, Atp2b1, Kcnd2) and glial (Gfap, Sorcs3, Aldh1l1, Olig2) markers in Pcp2TetTKO and wild type (WT).
Figure 4—figure supplement 2. Cytosine dynamics in Purkinje cell-specific triple knockout (Pcp2TetTKO).

Figure 4—figure supplement 2.

(A-C) Pcp2 cre/wt:: Tet1 del/del:: Tet2 del/del:: Tet3 del/del mice were crossed to ROSA26-eGFP reporter line to evaluate CRE expression during development. Panels represent murine cerebella at P0 (A), P7 (B), and P56 (C) timepoints in FL13, stained with anti-GFP antibody. (D) Anti-GFP staining in P56 FL19. (E) Expression of genes with increased and decreased expression in Pcp2TetTKO (boxplots in left panel, heatmaps in right panel). (F) Metagene plot of mean mCG and hmCG modifications over promoters and gene bodies of genes with increased or decreased expression in Pcp2TetTKO. (G) Cumulative DNA methylation valley (DMV) length per gene body between Pcp2TetTKO and wild type (WT). (H) Change in cumulative DMV length between adult Pcp2TetTKO and WT.

Altered transcription of PC expressed genes in Pcp2TetTKO

Loss of function studies of Tet1, Tet2, Tet3 and combinations thereof in ESCs and lymphocyte lineages have established that 5hmC plays a direct role in transcriptional regulation as a consequence of Tet-mediated replication-dependent loss of 5mC in enhancers, promoters, and gene bodies. To determine whether disruption of ongoing 5hmC accumulation in postmitotic PCs results in altered transcriptional regulation despite the inability to utilize passive DNA demethylation as a regulatory mechanism, we compared the transcriptome of adult Pcp2TetTKO mice with floxed Cre-negative littermates (WT). Using p < 0.05, log2 fold change of >0.5 in either direction to filter these data, we identified 721 genes whose transcription increases in the Pcp2TetTKO PCs and 548 genes with decreased levels of expression (Figure 4E, Supplementary file 3, Figure 4—figure supplement 2E-F). The large number of genes whose expression is impacted in the Pcp2TetTKO PCs is reminiscent of magnitude of changes documented in neurons in response to loss of MeCP2 (Chahrour et al., 2008) and other proteins involved nuclear organization and chromatin structure (Hyun et al., 2017). GO analysis of these two classes of genes revealed differences in the biological categories represented (Figure 4F). It is noteworthy that genes whose expression increases in the Pcp2TetTKO PCs are enriched for functions involved in terminal developmental events such as cell projection organization, synaptic transmission, and neuron differentiation. These include many ion channels, and receptors that should impact the fine-tuned physiology of PCs (Figure 4E–F, dark blue dots, Supplementary file 3), although given the complex firing patterns and action potential (AP) waveforms characteristic of PCs, it is difficult to predict the functional consequences of these changes. In contrast, genes whose expression is less in Pcp2TetTKO PCs are primarily involved in homeostasis and metabolic control. These are enriched in DNA transmembrane receptors and nucleic acid-binding proteins that may help regulate PC metabolism in response to external signals.

DNA demethylation in postmitotic PCs requires 5hmC

To assess the loss of 5mC and 5hmC in differentiating PCs reflects a direct role of TET proteins in transcriptional regulation as a consequence of loss of 5mC in enhancers, promoters, and gene bodies, we first identified candidate regulatory domains by comparative analysis of P0 and adult ATACSeq data to detect changes in chromatin accessibility that occur during PC differentiation. We then focused on those regions associated with genes that are transcriptionally impacted in the Pcp2TetTKO. As shown in Figure 4G, PC regulatory sites that become more accessible as differentiation proceeds lose both 5mCG and 5hmCG between P7 and adult whether their expression increases or decreases in the Pcp2TetTKO cells. The increased 5mCG and 5hmCG evident over these sites in the Pcp2TetTKO relative to WT PCs indicates clearly that loss of both 5mCG and 5hmCG at these sites requires continued Tet oxidase activity.

The requirement for continued 5hmC production in DNA demethylation is particularly evident from analysis of those very highly expressed genes that lose both 5mCG and 5hmCG over the gene body as differentiation proceeds (Figure 3). Genes with very large DMVs that are acquired early in development, for example, Hox cluster genes and Calb1, are not impacted in the Pcp2TetTKO PCs (Figure 4H, I). This is expected because DNA demethylation for these genes is evident before recombination and loss of Tet oxidase function occurs in the Pcp2TetTKO lines at approximately postnatal day 7 (Figure 4—figure supplement 2A-D). In contrast, for those genes that acquire large DMVs between P7 and adult, for example Gpr63 and Grid2, the loss of DNA methylation that is required for formation of the DMVs is strongly decreased (Figure 4H, I). As shown in the metagene plots of DNA displaying 5mCG and 5hmCG levels of this class of genes over the gene body (Figure 4I, right panel), the loss of both 5mCG and 5hmCG that occurs between P7 and adult is strongly impacted. Thus, the low levels of 5hmCG and 5mCG characteristic of this class of genes is not attained in the absence of Tet oxidase activity.

Formation of large DMVs in PC genes differs in detail depending on the timing and rate of transcription and the size of the gene. Gpr63 is strongly activated during postnatal life to become one of the most actively transcribed genes in adult PCs and it becomes nearly completely demethylated over the entire 46 kb of its gene body. Grid2 is a very long gene (~1.44 Mb) whose transcription also increases as differentiation proceeds. The Grid2 DMV also fails to develop fully in the Pcp2TetTKO (Figure 4H). In this case, the large DMV develops over only the promoter and initial 5’ region of the gene. In these two cases, and in other genes of this class, the growth of the DMV is preceded by the accumulation of 5hmC, DNA demethylation is initiated at the 5’ end of the gene, and it spreads toward the 3’ end as differentiation proceeds (Figure 4H). To understand better this variation in DNA demethylation in individual genes, we calculated the difference in the length of large DMVs over each gene in this class in the WT and Pcp2TetTKO PCs, and plotted these values as the negative length change (Figure 4—figure supplement 2G, H). These data revealed a large variation in the length of the DMV that does not form in the Pcp2TetTKO PCs. We believe this reflects a complex relationship between the timing at which transcription is initiated, the rate of transcription over the entire gene body, the local activity of Tet oxidase within the gene as differentiation proceeds, and the timing of Tet oxidase loss from each cell following recombination at the Tet1, Tet2, and Tet3 loci.

Taken together, these data demonstrate that loss of DNA methylation occurs over specific subsets of regulatory sites and transcription units in postmitotic Purkinje neurons. This loss of 5mCG requires continued production of 5hmC by Tet1, Tet2, and Tet3. The simplest interpretation of these data is that Tet-mediated active demethylation can occur in neurons as a result of continued oxidation of 5hmC to 5fC and 5caC, followed by their removal through the BER pathway.

Discussion

Since the discoveries that 5hmC is present at high levels in mammalian neuronal genomes (Kriaucionis and Heintz, 2009) and that it is produced from 5mC by the Tet oxidases (Tahiliani et al., 2009), its possible roles as a stable epigenetic mark and as an intermediate in DNA demethylation have been intensively investigated (Wu and Zhang, 2017). The present study adds to a growing body of work demonstrating that 5hmC plays a critical role in development and function of the nervous system. A central finding of this study is that continued Tet activity and 5hmC accumulation during PC differentiation is necessary for acquisition of their refined transcriptional and epigenetic properties. It is noteworthy that these phenotypes are evident despite loss of Tet function in the Pcp2TetTKO late in PC differentiation. It seems likely based on these findings and the gradual accumulation of 5hmC evident in our data that there is a continual requirement for 5hmC as a driver for epigenetic remodeling in most differentiating, postmitotic neurons. Although studies of neural stem cells (Li et al., 2015; Xu et al., 2012), cerebellar granule cells (Zhu et al., 2016), and embryonic brain development have suggested that 5hmC plays a significant role in neural progenitors and developing granule cells, a continual requirement for 5hmC may be particularly important for PCs, pyramidal cells, and other long range projection neurons whose differentiation program includes postmitotic development of sophisticated morphological features and abundant synapses.

A second principle that has emerged from our studies is that Tet-mediated active DNA demethylation occurs in postmitotic neurons. Our finding that loss of both 5mC and 5hmC in a specific subset of highly expressed gene bodies and ATAC accessible regulatory sites requires Tet oxidase activity provides critical in vivo evidence supporting studies in vitro (Weber et al., 2016) and in cultured cells (He et al., 2011) that have defined this pathway. For some genes (Gpr63, Grid2) the progression toward loss of modified C is easily appreciated. In these cases, conversion of 5mCG to 5hmCG over the gene body is clearly evident between P0 and P7, and continued Tet activity is required to remove both residual 5mCG and 5hmCG to result in DNA demethylation in the adult. Although we have been unable to detect 5fC and 5caC as transient intermediates in this process (Figure 3—figure supplement 1L), this is not surprising given the very small fraction of the PC genome that undergoes active DNA demethylation and the small amounts of genomic DNA that can be obtained from this very rare cell population. Identification of additional components of the of the DNA demethylation pathway that is occurring in PCs will require further genetic studies disrupting candidate genes in the TDG-BER pathway. Since important non-cell autonomous events are required for PC differentiation (Leto et al., 2016), we believe that additional PC-specific knockouts that are restricted to postmitotic cells will be most informative.

An important question arising from these findings is which cells in the nervous system require Tet-dependent active DNA demethylation to complete their developmental programs. Given these data, it seems likely other large neurons with complex and prolonged postmitotic differentiation programs share this requirement. Furthermore, reports that remodeling of DNA methylation may occur in response to a wide variety of stimuli in adult mice (Kaas et al., 2013; Rudenko et al., 2013) suggest that additional studies of Pcp2TetTKO and other precisely constructed mouse models will help elucidate possible functions of 5hmC in neuronal plasticity.

A third advance reported here is the collection of very high-resolution data to understand details of the relationships between DNA methylation and hydroxymethylation, chromatin accessibility, and chromatin organization in a single complex neuronal cell type as it develops from a primitive neuronal precursor to a fully articulated adult neuron. These data have highlighted several features of epigenetic development that remain to be explored including the definition of two distinct relationships between non-CG DNA methylation/hydroxymethylation and transcriptional repression, and the mechanism for selection of specific genes as substrates for active DNA demethylation. Taken together, our data demonstrate that disruption of continued 5hmC formation in the Pcp2TetTKO postmitotic PCs leads to altered transcription of late expressed genes, including a set of ion channels that may be responsible for refining their adult electrophysiological properties.

Although our data reinforce prior studies of the general relationships between DNA methylation, transcription, and chromatin structure, we note that there are many exceptions that require further investigation. One intriguing example is the very different relationships between genes and de novo methylation in CG and non-CG contexts (Lister et al., 2013). In PCs, as in other neurons, substantial enrichment of 5hmCG relative to its general accumulation genome wide occurs in active transcription units, suggesting a mechanism that targets Tet activity to these regions (Figure 2C). While accumulation of 5mCH and 5hmCH can occur within a repressed transcription unit with very nice discrimination between the gene and its surroundings (e.g. Pitpnc1), there are many regions of 5mCH and 5hmCH accumulation that either partially overlap with a gene, or that are present in intergenic regions (e.g. Myo5b/Scarna17/Lipg locus). In all of these regions, however, 5hmC accumulation directly reflects 5mCH levels suggesting 5hmCH localization reflects the pattern of de novo DNA methylation rather than targeted Tet activity. We hope that continued analysis of these datasets will provide a stimulus for additional studies of the mechanisms determining the relative distributions of these important events.

Concluding remarks

The data we have reported here advances our understanding of three major functions for 5hmC in the nervous system. Based on extensive studies of the requirements for Tet-mediated replication-dependent passive DNA demethylation in mESCs, the maturation of the germline, and developing lymphocyte lineages, it is probable that 5hmC is required to provide accessibility to important regulatory sites as neuronal progenitors exit the cell cycle and begin differentiation. The lack of DNA methylation we have observed at P0 over transcription factor genes (Lhx5, Lhx1, Ldb) that are expressed immediately after PCs exit from the cell cycle suggests that this may result from passive demethylation in dividing progenitors. Further support comes from the observation that DNA demethylation has been observed in comparisons of 5mC and 5hmC levels in the frontal cortex of fetal versus adult mouse and human brains, and the finding that a fraction of these loci retain their methylation status in Tet2-/- mice (Lister et al., 2013). A second function discovered in mature neurons involves stable accumulation of 5hmCG within active genes which helps to reverse the repressive effects of MeCP2 in a process we refer to as functional demethylation (Mellén et al., 2017). The finding that elevated 5hmC remains within genes that are repressed during PC differentiation (Figure 2C) adds to this model the fact that functional demethylation is not sufficient to maintain gene expression. Finally, we report here that Tet-mediated active DNA demethylation is required for proper expression of a subset of highly expressed PC-specific genes, adding a third important function for 5hmC in the nervous system. These findings place additional emphasis on investigation of ongoing functions of the TDG-BER pathway as elements of normal neuronal development rather than responses to accumulating DNA damage. Given these data and recent studies linking Tet mutations to neurodegenerative disease (Cochran et al., 2020; Marshall et al., 2020), it is evident that further exploration of each of these functions in the context of development, aging, and degeneration will continue enhance our understanding of 5hmC and the brain.

Materials and methods

Key resources table.

Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Strain, strain background (Mus musculus) Wild type Jackson Labs RRID:IMSR_JAX:000664
Strain, strain background (Mus musculus) Tet1 fl/fl:: Tet2 fl/fl:: Tet3 fl/fl Anjana Rao
Strain, strain background (Mus musculus) Tet1 fl/fl:: Tet2 fl/fl:: Tet3 fl/fl:: Pcp2-CRE This paper This line was generated as described in the Materials and methods section ‘Pcp2TetTKO murine strain generation’
Recombinant DNA reagent Pcp2-CRE (BAC construct) GENSAT RP24-186D18
Antibody Anti-Itpr1 (mouse monoclonal) Origene Origene: TA326547 (1:500)
Antibody Anti-Itpr1 (mouse monoclonal) Abcam Abcam: ab190239 (1:500)
Antibody Anti-Calb1 (rabbit polyclonal) Immunostar RRID: AB_572222Immunostar: 24,427 (1:500)
Antibody Anti-H3K27me3 (rabbit polyclonal) Active motif RRID: AB_2561020Active motif: 39,155 (4 µL)
Antibody Anti-H3K4me3 (rabbit polyclonal) Active motif RRID: AB_2615077Active motif: 39,159 (4 µL)
Antibody Anto-GFP (chicken polyclonal) Abcam Abcam: ab13970 (1:500)
Sequence-based reagent Raw and processed sequencing data This paper GSE166423 The sequencing data was generated as described in the Materials and methods section ‘Sequencing methods’
Commercial assay or kit AllPrep FFPE Qiagen Qiagen: 80,234
Commercial assay or kit Low Cell ChIPSeq kit Active motif Active motif: 53,084
Commercial assay or kit Ultralow MethylSeq with Trumethyl OxBS Tecan Genomics Tecan Genomics: 0414–32
Commercial assay or kit Nextera library prep kit Illumina Illumina: FC-131–1024
Commercial assay or kit Bioanalyzer Pico Agilent Agilent: 5067–1513
Commercial assay or kit TapeStation High sensitivity D1000 Agilent Agilent: 5067–5593

Animals

Wild-type C57BL6/J (RRID:IMSR_JAX:000664) were obtained from Jackson Laboratories. Animals were maintained on a 12 hr light/12 hr dark cycle with food and water ad libitum. Animal protocols were approved by the Rockefeller University Institutional Animal Care and Use Committee, in accordance with the US National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Pcp2TetTKO murine strain generation

Tet1fl/fl::Tet2fl/fl::Tet3fl/fl animals were a gift from Anjana Rao. We used a previously characterized Pcp2-CRE BAC (RP24-186D18) construct from the GENSAT project (Gong et al., 2007; Gong et al., 2003) to create a conditional TKO in PCs. Pronuclear injections of the BAC construct into zygotes were performed at the Transgenic and Reproductive Technology Center at the Rockefeller University.

Cell type-specific nuclei isolation

Nuclei isolation

Nuclei isolation protocol was followed as described (Xu et al., 2018). Briefly, mouse cerebella were dissected and flash-frozen using liquid nitrogen. To isolate nuclei, tissue was thawed on ice for 30 min and then transferred to 5 mL of homogenization buffer (0.25 M sucrose, 150 mM KCl, 5 mM MgCl2, 20 mM Tricine pH 7.8, 0.15 mM spermine, 0.5 mM spermidine, EDTA-free protease inhibitor cocktail, 1 mM DTT, 20 U/mL Superase-In RNase inhibitor, 40 U/mL RNasin ribonuclease inhibitor). Tissue was homogenized by 30 strokes of loose (A) followed by 30 strokes of tight (B) glass dounce. Homogenate was supplemented with 5 mL of a 50% iodixanol solution (50% Iodixanol/Optiprep, 150 mM KCl, 5 mM MgCl2, 20 mM Tricine pH 7.8, 0.15 mM spermine, 0.5 mM spermidine, EDTA-free protease inhibitor cocktail, 1 mM DTT, 20 U/mL Superase-In RNase inhibitor, 40 U/mL RNasin ribonuclease inhibitor), and laid on a 27% iodixanol cushion. Nuclei were pelleted by centrifugation 30 min, 10,000 rpm, 4°C in swinging bucket rotor (SW41) in a Beckman Coulter XL-70 ultracentrifuge. The nuclear pellet was resuspended in homogenization buffer.

Nuclei labeling and sorting

Nuclei were fixed with 1% formaldehyde for 8 min at RT with mild agitation. The crosslinking reaction was quenched with 0.125 M glycine for 5 min at RT. Nuclei were pelleted at 1000 g, 4 min, 4°C, and then washed two times with Wash Buffer (PBS, 0.05% Triton X-100, 50 ng/mL BSA, 1 mM DTT, 10 U/µL Superase-In RNase Inhibitor). Nuclei were blocked with Block Buffer (Wash Buffer with an additional 50 ng/mL BSA) for 30 min at RT, incubated with primary antibody for 1 hr at RT, and then washed three times with Wash Buffer with spins in-between washes as described above. Nuclei were then incubated in secondary antibody for 30 min at RT and washed three times with Wash Buffer. Primary and secondary antibodies were diluted in Block Buffer. Secondary antibodies were purchased from Life Technologies or Jackson Immunoresearch and were used at 1:500 dilution. Secondary antibodies from goat used: mouse Alexa488, rabbit Alexa594.

FACS

Nuclei were stained with DyeCycle Ruby to 20 µM final concentration. Nuclei were sorted using a BD FACSAria cell sorter using the 488 and 561 nm lasers. First, samples were gated using DyeCycle Ruby to select only singlets, then appropriate populations were gated based on their separation. Analysis was performed using FlowJo software. Qiagen Buffer PKD was added to the sorted nuclei and the samples were stored at –80°C.

Immunohistochemistry

Mice were decapitated at P0 and P7, and the brains were dissected, and immersion fixed in 4% formaldehyde (w/v) overnight at 4°C. Adult mice were deeply anesthetized and then the brains were fixed by transcardiac perfusion with PBS followed by 4% formaldehyde. Brains were further fixed by immersion fixation in 4% formaldehyde overnight at 4°C. All brains were cryoprotected in 30% sucrose in PBS, embedded in OCT, and cut with a Leica CM3050 S cryostat into 20 µm sections. The sections were immediately mounted on slides and stored at –20°C. Antigen retrieval using sodium citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0) was performed by heating the slides to 95–100°C and then 10 min incubation in the microwave at the lowest power. The slides were cooled off to RT for 1 hr. The slides were washed in PBS and blocked with 3% BSA in PBS with 0.1% Triton X-100 for 30 min at RT. Primary antibody incubation was performed overnight at RT, washed with PBS, incubated with secondary antibody for 1 hr at RT, washed with PBS, stained with DAPI (1:10000) for 10 min at RT and washed three times with PBS. Slides were cover-slipped with Prolong Diamond mounting media. Images were acquired using a Zeiss LSM700 confocal microscope using the same acquisition settings for all samples. Further image analysis was done using FIJI.

Sequencing methods

RNASeq

RNA and gDNA from fixed nuclei were purified using the Qiagen AllPrep FFPE kit with the following modifications. After DNA/RNA separation spin, the RNA-containing supernatant was removed and incubated at 65°C for 30 min, 70°C for 30 min, and 80°C for 15 min and then proceeded with the manufacturer’s protocol. gDNA was purified following the rest of the manufacturer’s protocol. RNA quality was determined using Agilent 2100 Bioanalyzer. Purified RNA was converted to cDNA and amplified using the Nugen Ovation RNA-Seq System V2. cDNA was fragmented to an average size of 200 bp using a Covaris C2 sonicator (intensity 5, duty cycle 10%, cycles per burst 200, treatment time 120 s). Libraries were prepared using the NEBNext Ultra DNA Library Prep Kit for Illumina with NEBNext Multiplex Oligos for Illumina. The quality of the libraries was assessed using the Agilent 2200 TapeStation system with D1000 High Sensitivity ScreenTape. Libraries were sequenced at The Rockefeller University Genomics Resource Center on the Illumina NextSeq 500 to obtain 75 bp paired-end reads.

ATAC-Seq

ATACSeq libraries were prepared as described (Buenrostro et al., 2013; Chen et al., 2016) with minor modifications; ~25 k fixed nuclei were incubated for 10 min in lysis buffer (10 mM Tris pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40). Nuclei were then resuspended in 50 µL 1× TD buffer containing 2.5 µL Tn5 enzyme from Nextera (Illumina) and incubated for 30 min at 37°C; 200 µL of reverse-crosslinking buffer (50 mM Tris-Cl, 1 mM EDTA, 1 % SDS, 0.2 M NaCl, 5 ng/mL proteinase K) was added to the samples and they were incubated overnight at 65°C with shaking. The samples were then purified using the QiaQuick MinElute columns (Qiagen). Libraries were amplified by PCR using the Q5 High Fidelity Polymerase (NEB) for 12 cycles with barcoded primers. Libraries were size-selected with AMPure XP beads (Beckman Coulter). Libraries were sequenced at The Rockefeller University Genomics Resource Center on Illumina NextSeq 500 to yield 75 bp paired-end reads.

OxBSSeq

DNA conversion and library preparation were performed using the CEGX TrueMethyl-Seq Whole Genome kit (Cambridge Epigenetix, Cambridge, UK) and after its acquisition from Tecan, the Ultralow Methyl-Seq with TrueMethyl OxBS Module (#0541 and #9513) following the manufacturer’s instructions. Briefly, the DNA was sheared to 800 bp using Covaris sonicator and treated with the oxidation agent and bisulfite following the manufacturer’s protocol. Libraries were sequenced on Illumina NextSeq 500 to yield 75 bp paired-end reads. The efficiency of the DNA oxidation and conversion was assessed by interrogating the spike-in Digestion Control and Sequencing Control using the dockerized custom pipeline bsExpress from CEGX (https://bitbucket.org/cegx-bfx/cegx_bsexpress) and fell within the expected ranges (≥90% for hmC conversion in the OxBs reaction, <10% for hmC conversion in the BS reaction (hmC/BS over-conversion error rate), <5% for mC conversion in both the OxBs and BS reactions (over-conversion error rate)).

ChIPSeq

Chromatin immunoprecipitation was performed using the Low Cell ChIPSeq kit (#53048, Active Motif) following the manufacturer’s instructions. Libraries were prepared using the supplied library prep reagents. The samples were sequenced on Illumina NextSeq 500 to yield 75 bp paired-end reads.

Bioinformatic data analysis

Most data analysis was done in the R/Bioconductor environment (Huber et al., 2015) in RStudio (https://www.R-project.org/, http://www.rstudio.com/). For general processing, data exploration, and visualization, we used the tidyverse array of packages, in particular ggplot and dplyr (Wickham et al., 2019).

RNASeq

RNASeq reads were aligned using STAR (Dobin et al., 2013) and genome assemblies from UCSC. In addition to default STAR parameters, we used the following for paired-end data (--outFilterMismatchNmax 999 --alignMatesGapMax 1000000 -- outFilterScoreMinOverLread 0 --outFilterMatchNminOverLread 0 --outFilterMatchNmin 60 -- outFilterMismatchNoverLmax 0.05). Aligned reads were converted to bigwigs for visualization in IGV (Robinson et al., 2011) using deepTools (Ramírez et al., 2016). UCSC gene model annotations for whole genes were downloaded using the UCSC Table Browser tool. Transcript level quantifications was performed using Salmon (v1.1.0) (Patro et al., 2017) and imported for differential expression analysis with tximport (v1.10.1) (Soneson et al., 2015) and DESeq2 (v1.22.2) (Love et al., 2014). For up- and down-regulated genes, we selected for a log2 fold change of 2 and p-adjusted value of 0.05. GO analysis was performed using GOrilla (http://cbl-gorilla.cs.technion.ac.il/) (Eden et al., 2009) or DAVID (https://david.ncifcrf.gov) (Huang et al., 2009).

ATACSeq

Reads were processed with trim_galore (Martin, 2011) with parameters ‘--stringency 3 --fastqc --paired’. Trimmed reads were mapped to mm10 using bowtie2 (version 2.1.0) (Langmead and Salzberg, 2012) with parameters ‘-X 2000 --no-mixed --no-discordant’. Duplicates were removed using samtools (Li et al., 2009). Reads were normalized to RPKM using deepTools bamCompare module, ignoring chrX, chrY, chrM and filtering reads for minimum mapping quality of 30. Metagene and heatmap profiles were generated using deepTools modules computeMatrix, plotProfile, and plotHeatmap. Unique fragments under 100 nt were used to call peaks with macs2 (Zhang et al., 2008) with parameters ‘--nomodel -q 0.01 --call-summits’. Broad peaks were called with macs2 as well with parameters ‘--nomodel -f BAM --keep-dup all --broad -g mm -B -q 0.01’. The peaks were filtered to remove chrY and chrM peaks and peaks that overlap with the mm10 blacklist from ENCODE (ENCODE Project Consortium, 2012). DiffBind (v2.10.0) (Ross-Innes et al., 2012) was used to identify differentially accessible chromatin regions using the DESeq2 method. Peaks were selected based on fourfold difference and q-value of 0.05. Differential motif enrichment was performed using chromVAR (v1.4.1) (Schep et al., 2017).

OxBSSeq

Reads were processed with trim_galore with parameters ‘--stringency 3 --fastqc --paired --clip_R1 5 --clip_R2 10’. Trimmed reads were mapped to mm10 using bismark (Krueger and Andrews, 2011) with parameters ‘--bowtie2 -p 4 --multicore 4’ (v0.20.0). Duplicates were removed using deduplicate_bismark. The following tools from methpipe (v3.4.2) (Song et al., 2013) were used for downstream statistical estimation of the methylation and hydroxymethylation levels. First, bismark aligned reads were converted to the custom.mr format and sorted with default parameters. Methylation calls were extracted with methcounts with default parameters. Methylation and hydroxymethylation levels were estimated using the mlml tool with default parameters. Genome browser files were generated with bedGraphToBigWig. UMRs and low methylated regions (LMRs) were identified using MethylSeekR (v1.22.0) (Burger et al., 2013) with m = 0.5% and 5% FDR. DMVs were identified as UMRs ≥ 5 kb with mean.meth ≤ 15 and regions within 1 kb of each other were merged (bedtools merge -d 1000). mm10 CpG island annotations were downloaded from the UCSC table browser. Unique large DMVs were selected by excluding regions under 15 kb. The regions were annotated using HOMER (Heinz et al., 2010). DMR analysis was performed using methylpy (v1.3.4) (Schultz et al., 2015) with default parameters.

ChIPSeq

Reads were processed with trim_galore with parameters ‘--stringency 3 --fastqc --paired’. Trimmed reads were mapped to mm10 using bowtie2 (v2.1.0) with default parameters. Duplicates were removed using samtools. QC was performed with ChIPQC (Carroll et al., 2014) and that estimated fragment size was used for broad peak calling with macs2 (--nomodel -f BAM --keep-dup all --broad -g mm -B -q 0.01).

Antibody list

Antigen Species Vendor Cat # RRID Dilution
Itpr1* Clone ID: S24-18 Mouse Origene TA326547 FACS 1:500IF 1:500
Itpr1* S24-18 Mouse Abcam ab190239 FACS 1:500IF 1:500
Calb1 Rabbit Immunostar 24427 AB_572222 IF 1:500
GFP Chicken Abcam ab13970 IF 1:500
H3K27me3 Rabbit Active Motif 39155 AB_2561020 ChIP 4 µL
H3K4me3 Rabbit Active Motif 39159 AB_2615077 ChIP 4 µL
*Same clone, discontinued at Abcam

Acknowledgements

We thank all Heintz lab members from the past and present for thoughtful discussions and suggestions. We thank Thomas Carroll, Ji-Dung Luo, Matthew Paul, Doug Barrows, and Wei Wang from the Rockefeller University Bioinformatics Resource Core; Svetlana Mazel, Selamawit Tadesse, Stanka Semova, Songyan Han and Samer Shalaby from The Rockefeller University Flow Cytometry Resource Center; Connie Zhao and Christine Lai from The Rockefeller University Genomics Resource Center; Rada Norinsky from the Rockefeller University Transgenic and Reproductive Technology Center.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Nathaniel Heintz, Email: heintz@rockefeller.edu.

Anne E West, Duke University School of Medicine, United States.

Catherine Dulac, Harvard University, United States.

Funding Information

This paper was supported by the following grants:

  • Howard Hughes Medical Institute to Nathaniel Heintz.

  • National Cancer Institute R35 CA210043 to Anjana Rao.

Additional information

Competing interests

No competing interests declared.

No competing interests declared.

Author contributions

Conceptualization, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review and editing.

Formal analysis, Investigation, Writing – review and editing.

Resources, Writing – review and editing.

Conceptualization, Funding acquisition, Resources, Supervision, Writing – original draft, Writing – review and editing.

Ethics

Animal protocols (20033 and 16944) were approved by the Rockefeller University Institutional Animal Care and Use Committee, in accordance with the US National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Additional files

Supplementary file 1. Developmental differentially expressed genes between P0 and adult Purkinje cells.
elife-66973-supp1.xlsx (261.5KB, xlsx)
Supplementary file 2. DNA methylation valleys (DMVs) identified in adult Purkinje neurons.
elife-66973-supp2.xlsx (11.5KB, xlsx)
Supplementary file 3. Differentially expressed genes in the adult triple Tet proteins knockout.
elife-66973-supp3.xlsx (140.1KB, xlsx)
Transparent reporting form

Data availability

Pcp2TetTKO mice will be made available with a Material Transfer Agreement (MTA). Sequencing data is available on NCBI Gene Expression Omnibus under accession number GSE166423. Code for data analysis is available at https://github.com/estoyanova/EStoyanova_eLife_2021 copy archived at https://archive.softwareheritage.org/swh:1:rev:4c2fa6c102e4f868fc91e0dcb0b8c7155b8f8712.

The following dataset was generated:

Stoyanova E, Riad M, Rao A, Heintz N. 2021. 5-hydroxymethylcytosine is required for terminal differentiation of Purkinje neurons. NCBI Gene Expression Omnibus. GSE166423

References

  1. Ayata P. Student Theses and Dissertations; 2013. Decoding 5HMC as an Active Chromatin Mark in the Brain and Its Link to Rett Syndrome.https://digitalcommons.rockefeller.edu/student_theses_and_dissertations/238/ [Google Scholar]
  2. Booth MJ, Ost TWB, Beraldi D, Bell NM, Branco MR, Reik W, Balasubramanian S. Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine. Nature Protocols. 2013;8:1841–1851. doi: 10.1038/nprot.2013.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nature Methods. 2013;10:1213–1218. doi: 10.1038/nmeth.2688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burger L, Gaidatzis D, Schübeler D, Stadler MB. Identification of active regulatory regions from DNA methylation data. Nucleic Acids Research. 2013;41:e155. doi: 10.1093/nar/gkt599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Butts T, Green MJ, Wingate RJT. Development of the cerebellum: simple steps to make a “little brain”. Development. 2014;141:4031–4041. doi: 10.1242/dev.106559. [DOI] [PubMed] [Google Scholar]
  6. Carroll TS, Liang Z, Salama R, Stark R, de Santiago I. Impact of artifact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data. Frontiers in Genetics. 2014;5:75. doi: 10.3389/fgene.2014.00075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chahrour M, Jung SY, Shaw C, Zhou X, Wong STC, Qin J, Zoghbi HY. MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription. Science. 2008;320:1224–1229. doi: 10.1126/science.1153252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen X, Shen Y, Draper W, Buenrostro JD, Litzenburger U, Cho SW, Satpathy AT, Carter AC, Ghosh RP, East-Seletsky A, Doudna JA, Greenleaf WJ, Liphardt JT, Chang HY. ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing. Nature Methods. 2016;13:1013–1020. doi: 10.1038/nmeth.4031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chizhikov VV, Lindgren AG, Currle DS, Rose MF, Monuki ES, Millen KJ. The roof plate regulates cerebellar cell-type specification and proliferation. Development. 2006;133:2793–2804. doi: 10.1242/dev.02441. [DOI] [PubMed] [Google Scholar]
  10. Cochran JN, Geier EG, Bonham LW, Newberry JS, Amaral MD, Thompson ML, Lasseigne BN, Karydas AM, Roberson ED, Cooper GM, Rabinovici GD, Miller BL, Myers RM, Yokoyama JS, Alzheimer’s Disease Neuroimaging Initiative Non-coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases. American Journal of Human Genetics. 2020;106:632–645. doi: 10.1016/j.ajhg.2020.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dawlaty MM, Breiling A, Le T, Raddatz G, Barrasa MI, Cheng AW, Gao Q, Powell BE, Li Z, Xu M, Faull KF, Lyko F, Jaenisch R. Combined Deficiency of Tet1 and Tet2 Causes Epigenetic Abnormalities but Is Compatible with Postnatal Development. Developmental Cell. 2013;24:310–323. doi: 10.1016/j.devcel.2012.12.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi: 10.1093/bioinformatics/bts635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009;10:48. doi: 10.1186/1471-2105-10-48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74. doi: 10.1038/nature11247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Feil R, Hartmann J, Luo C, Wolfsgruber W, Schilling K, Feil S, Barski JJ, Meyer M, Konnerth A, De Zeeuw CI, Hofmann F. Impairment of LTD and cerebellar learning by Purkinje cell-specific ablation of cGMP-dependent protein kinase I. The Journal of Cell Biology. 2003;163:295–302. doi: 10.1083/jcb.200306148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gabel HW, Kinde B, Stroud H, Gilbert CS, Harmin DA, Kastan NR, Hemberg M, Ebert DH, Greenberg ME. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature. 2015;522:89–93. doi: 10.1038/nature14319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Globisch D, Münzel M, Müller M, Michalakis S, Wagner M, Koch S, Brückl T, Biel M, Carell T. Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates. PLOS ONE. 2010;5:e15367. doi: 10.1371/journal.pone.0015367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner A, Leblanc G, Hatten ME, Heintz N. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature. 2003;425:917–925. doi: 10.1038/nature02033. [DOI] [PubMed] [Google Scholar]
  19. Gong S, Doughty M, Harbaugh CR, Cummins A, Hatten ME, Heintz N, Gerfen CR. Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. The Journal of Neuroscience. 2007;27:9817–9823. doi: 10.1523/JNEUROSCI.2707-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Guo JU, Su Y, Zhong C, Ming G, Song H. Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain. Cell. 2011;145:423–434. doi: 10.1016/j.cell.2011.03.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song CX, Zhang K, He C, Xu GL. Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA. Science. 2011;333:1303–1307. doi: 10.1126/science.1210944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities. Molecular Cell. 2010;38:576–589. doi: 10.1016/j.molcel.2010.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols. 2009;4:44–57. doi: 10.1038/nprot.2008.211. [DOI] [PubMed] [Google Scholar]
  24. Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T, Gottardo R, Hahne F, Hansen KD, Irizarry RA, Lawrence M, Love MI, MacDonald J, Obenchain V, Oleś AK, Pagès H, Reyes A, Shannon P, Smyth GK, Tenenbaum D, Waldron L, Morgan M. Orchestrating high-throughput genomic analysis with Bioconductor. Nature Methods. 2015;12:115–121. doi: 10.1038/nmeth.3252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hyun K, Jeon J, Park K, Kim J. Writing, erasing and reading histone lysine methylations. Experimental & Molecular Medicine. 2017;49:e324. doi: 10.1038/emm.2017.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine. Science. 2011;333:1300–1303. doi: 10.1126/science.1210597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Iyer LM, Tahiliani M, Rao A, Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle. 2009;8:1698–1710. doi: 10.4161/cc.8.11.8580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jeong M, Sun D, Luo M, Huang Y, Challen GA, Rodriguez B, Zhang X, Chavez L, Wang H, Hannah R, Kim SB, Yang L, Ko M, Chen R, Göttgens B, Lee JS, Gunaratne P, Godley LA, Darlington GJ, Rao A, Li W, Goodell MA. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nature Genetics. 2014;46:17–23. doi: 10.1038/ng.2836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming G, King JR, Song H, Sweatt JD. TET1 Controls CNS 5-Methylcytosine Hydroxylation, Active DNA Demethylation. Gene Transcription, and Memory Formation. Neuron. 2013;79:1086–1093. doi: 10.1016/j.neuron.2013.08.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kriaucionis S, Heintz N. The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain. Science. 2009;324:929–930. doi: 10.1126/science.1169786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27:1571–1572. doi: 10.1093/bioinformatics/btr167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature Methods. 2012;9:357–359. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Leto K, Arancillo M, Becker EBE, Buffo A, Chiang C, Ding B, Dobyns WB, Dusart I, Haldipur P, Hatten ME, Hoshino M, Joyner AL, Kano M, Kilpatrick DL, Koibuchi N, Marino S, Martinez S, Millen KJ, Millner TO, Miyata T, Parmigiani E, Schilling K, Sekerková G, Sillitoe RV, Sotelo C, Uesaka N, Wefers A, Wingate RJT, Hawkes R. Consensus Paper: Cerebellar Development. Cerebellum. 2016;15:789–828. doi: 10.1007/s12311-015-0724-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–2079. doi: 10.1093/bioinformatics/btp352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Li T, Yang D, Li J, Tang Y, Yang J, Le W. Critical role of Tet3 in neural progenitor cell maintenance and terminal differentiation. Molecular Neurobiology. 2015;51:142–154. doi: 10.1007/s12035-014-8734-5. [DOI] [PubMed] [Google Scholar]
  36. Li Y, Zheng H, Wang Q, Zhou C, Wei L, Liu X, Zhang W, Zhang Y, Du Z, Wang X, Xie W. Genome-wide analyses reveal a role of Polycomb in promoting hypomethylation of DNA methylation valleys. Genome Biology. 2018;19:18. doi: 10.1186/s13059-018-1390-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lio CW, Zhang J, González-Avalos E, Hogan PG, Chang X, Rao A. Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility. eLife. 2016;5:e18290. doi: 10.7554/eLife.18290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Lio CWJ, Rao A. TET Enzymes and 5hmC in Adaptive and Innate Immune Systems. Frontiers in Immunology. 2019;10:210. doi: 10.3389/fimmu.2019.00210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lio CWJ, Shukla V, Samaniego-Castruita D, González-Avalos E, Chakraborty A, Yue X, Schatz DG, Ay F, Rao A. TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the Aicda superenhancer. Science Immunology. 2019;4:eaau7523. doi: 10.1126/sciimmunol.aau7523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, Lucero J, Huang Y, Dwork AJ, Schultz MD, Yu M, Tonti-Filippini J, Heyn H, Hu S, Wu JC, Rao A, Esteller M, He C, Haghighi FG, Sejnowski TJ, Behrens MM, Ecker JR. Global Epigenomic Reconfiguration During Mammalian Brain Development. Science. 2013;341:1237905. doi: 10.1126/science.1237905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology. 2014;15:550. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. MacArthur IC, Dawlaty MM. TET Enzymes and 5-Hydroxymethylcytosine in Neural Progenitor Cell Biology and Neurodevelopment. Frontiers in Cell and Developmental Biology. 2021;9:645335. doi: 10.3389/fcell.2021.645335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Marshall LL, Killinger BA, Ensink E, Li P, Li KX, Cui W, Lubben N, Weiland M, Wang X, Gordevicius J, Coetzee GA, Ma J, Jovinge S, Labrie V. Epigenomic analysis of Parkinson’s disease neurons identifies Tet2 loss as neuroprotective. Nature Neuroscience. 2020;23:1203–1214. doi: 10.1038/s41593-020-0690-y. [DOI] [PubMed] [Google Scholar]
  44. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.Journal. 2011;17:10. doi: 10.14806/ej.17.1.200. [DOI] [Google Scholar]
  45. McKay BE, Turner RW. Physiological and morphological development of the rat cerebellar Purkinje cell: Purkinje cell output parallels dendritic development. The Journal of Physiology. 2005;567:829–850. doi: 10.1113/jphysiol.2005.089383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N. MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous System. Cell. 2012;151:1417–1430. doi: 10.1016/j.cell.2012.11.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mellén M, Ayata P, Heintz N. 5-hydroxymethylcytosine accumulation in postmitotic neurons results in functional demethylation of expressed genes. PNAS. 2017;114:E7812–E7821. doi: 10.1073/pnas.1708044114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Mo A, Mukamel EA, Davis FP, Luo C, Henry GL, Picard S, Urich MA, Nery JR, Sejnowski TJ, Lister R, Eddy SR, Ecker JR, Nathans J. Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain. Neuron. 2015;86:1369–1384. doi: 10.1016/j.neuron.2015.05.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Morales D, Hatten ME. Molecular Markers of Neuronal Progenitors in the Embryonic Cerebellar Anlage. The Journal of Neuroscience. 2006;26:12226–12236. doi: 10.1523/JNEUROSCI.3493-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Nan X, Bird A. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome. Brain and Development. 2001;23:S32–S37. doi: 10.1016/S0387-7604(01)00333-3. [DOI] [PubMed] [Google Scholar]
  51. Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nature Methods. 2017;14:417–419. doi: 10.1038/nmeth.4197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Piccolo FM, Liu Z, Dong P, Hsu CL, Stoyanova EI, Rao A, Tjian R, Heintz N. MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions. eLife. 2019;8:e51449. doi: 10.7554/eLife.51449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Ramírez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, Dündar F, Manke T. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Research. 2016;44:W160–W165. doi: 10.1093/nar/gkw257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. Integrative genomics viewer. Nature Biotechnology. 2011;29:24–26. doi: 10.1038/nbt.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, Ali S, Chin SF, Palmieri C, Caldas C, Carroll JS. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481:389–393. doi: 10.1038/nature10730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Rudenko A, Dawlaty MM, Seo J, Cheng AW, Meng J, Le T, Faull KF, Jaenisch R, Tsai LH. Tet1 Is Critical for Neuronal Activity-Regulated Gene Expression and Memory Extinction. Neuron. 2013;79:1109–1122. doi: 10.1016/j.neuron.2013.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Schep AN, Wu B, Buenrostro JD, Greenleaf WJ. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nature Methods. 2017;14:975–978. doi: 10.1038/nmeth.4401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Schultz MD, He Y, Whitaker JW, Hariharan M, Mukamel EA, Leung D, Rajagopal N, Nery JR, Urich MA, Chen H, Lin S, Lin Y, Jung I, Schmitt AD, Selvaraj S, Ren B, Sejnowski TJ, Wang W, Ecker JR. Human body epigenome maps reveal noncanonical DNA methylation variation. Nature. 2015;523:212–216. doi: 10.1038/nature14465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Research. 2015;4:1521. doi: 10.12688/f1000research.7563.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Song Q, Decato B, Hong EE, Zhou M, Fang F, Qu J, Garvin T, Kessler M, Zhou J, Smith AD. A Reference Methylome Database and Analysis Pipeline to Facilitate Integrative and Comparative Epigenomics. PLOS ONE. 2013;8:e81148. doi: 10.1371/journal.pone.0081148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Szulwach KE, Li X, Li Y, Song CX, Wu H, Dai Q, Irier H, Upadhyay AK, Gearing M, Levey AI, Vasanthakumar A, Godley LA, Chang Q, Cheng X, He C, Jin P. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nature Neuroscience. 2011;14:1607–1616. doi: 10.1038/nn.2959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1. Science. 2009;324:930–935. doi: 10.1126/science.1170116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Tsagaratou A, Äijö T, Lio CWJ, Yue X, Huang Y, Jacobsen SE, Lähdesmäki H, Rao A. Dissecting the dynamic changes of 5-hydroxymethylcytosine in T-cell development and differentiation. PNAS. 2014;111:E3315. doi: 10.1073/pnas.1412327111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Tsagaratou A, González-Avalos E, Rautio S, Scott-Browne JP, Togher S, Pastor WA, Rothenberg EV, Chavez L, Lähdesmäki H, Rao A. TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells. Nature Immunology. 2017;18:45–53. doi: 10.1038/ni.3630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Weber AR, Krawczyk C, Robertson AB, Kuśnierczyk A, Vågbø CB, Schuermann D, Klungland A, Schär P. Biochemical reconstitution of TET1-TDG-BER-dependent active DNA demethylation reveals a highly coordinated mechanism. Nature Communications. 2016;7:10806. doi: 10.1038/ncomms10806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Wickham H, Averick M, Bryan J, Chang W, McGowan LD, François R, Grolemund G, Hayes A, Henry L, Hester J, Kuhn M, Pedersen TL, Miller E, Bache SM, Müller K, Ooms J, Robinson D, Seidel DP, Spinu V, Takahashi K, Vaughan D, Wilke C, Woo K, Yutani H. Welcome to the Tidyverse. Journal of Open Source Software. 2019;4:1686. doi: 10.21105/joss.01686. [DOI] [Google Scholar]
  67. Wu X, Zhang Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nature Reviews. Genetics. 2017;18:517–534. doi: 10.1038/nrg.2017.33. [DOI] [PubMed] [Google Scholar]
  68. Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, Hawkins RD, Leung D, Yang H, Wang T, Lee AY, Swanson SA, Zhang J, Zhu Y, Kim A, Nery JR, Urich MA, Kuan S, Yen C, Klugman S, Yu P, Suknuntha K, Propson NE, Chen H, Edsall LE, Wagner U, Li Y, Ye Z, Kulkarni A, Xuan Z, Chung W-Y, Chi NC, Antosiewicz-Bourget JE, Slukvin I, Stewart R, Zhang MQ, Wang W, Thomson JA, Ecker JR, Ren B. Epigenomic Analysis of Multilineage Differentiation of Human Embryonic Stem Cells. Cell. 2013;153:1134–1148. doi: 10.1016/j.cell.2013.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Xu Y, Xu C, Kato A, Tempel W, Abreu JG, Bian C, Hu Y, Hu D, Zhao B, Cerovina T, Diao J, Wu F, He HH, Cui Q, Clark E, Ma C, Barbara A, Veenstra GJC, Xu G, Kaiser UB, Liu XS, Sugrue SP, He X, Min J, Kato Y, Shi YG. Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural Development. Cell. 2012;151:1200–1213. doi: 10.1016/j.cell.2012.11.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Xu X, Stoyanova EI, Lemiesz AE, Xing J, Mash DC, Heintz N. Species and cell-type properties of classically defined human and rodent neurons and glia. eLife. 2018;7:e37551. doi: 10.7554/eLife.37551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS. Model-based analysis of ChIP-Seq (MACS) Genome Biology. 2008;9:R137. doi: 10.1186/gb-2008-9-9-r137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Zhu X, Girardo D, Govek EE, John K, Mellén M, Tamayo P, Mesirov JP, Hatten ME. Role of Tet1/3 Genes and Chromatin Remodeling Genes in Cerebellar Circuit Formation. Neuron. 2016;89:100–112. doi: 10.1016/j.neuron.2015.11.030. [DOI] [PMC free article] [PubMed] [Google Scholar]

Editor's evaluation

Anne E West 1

This study comprehensively characterizes the regulation of chromatin in developing Purkinje neurons of the cerebellum and demonstrates a role for the Tet family of oxidases in controlling temporal changes in gene transcription during differentiation via active DNA demethylation.

Decision letter

Editor: Anne E West1

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

[Editor’s note: review comments and author responses relating to electrophysiology data, which were included in an earlier version, have been omitted.]

Congratulations, we are pleased to inform you that your article, "5-hydroxymethylcytosine mediated active demethylation is required for neuronal differentiation and function", has been accepted for publication in eLife.

Thank you for submitting your work entitled "5-hydroxymethylcytosine mediated active demethylation is required for neuronal differentiation and function" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The reviewers have opted to remain anonymous.

Reviewer #1 (Recommendations for the authors):

In this manuscript the authors carry out epigenomic profiling purified Purkinje cells across key stages of cerebellar development to study the regulation and function of 5hmC. The authors have previously published a method for isolation of FACS-based nuclear sorting for these cells and here they use it to isolate from P0, P7, and adult cerebellum with high quality RNA, mC/hmC, ATAC and ChIP-seq data at each time point in biological replicate. The chromatin data are correlated against developmental changes in gene expression and suggest broad mechanisms of chromatin control that are, for the most part, in line with previous studies of other cell types. The authors are particularly interested in regions of the genome that show loss of mCG (and hmCG) over developmental time and are near genes that show enhanced expression in adult PCs. They test the requirement for the Tets in the developmental demethylation of these regions by knocking out all three Tets in a PC specific manner at P7, then running RNA/mCG/hmCG sequencing in adult to compare between cTKO and control.

PCs are a biologically important class of neurons and they are a very different cell type from others that have been developmentally studied. For these reasons the descriptive chromatin data gathered here are of use to the community. However, the analyses performed on the data as presented here are somewhat underdeveloped. I

Reviewer #2 (Recommendations for the authors):

TET dioxygenases (TET1, TET2, TET3) mediate the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), which may lead to additional forms of DNA modifications and ultimately DNA demethylation. In dividing cells, the maintenance DNA methyltransferase recognizes poorly of 5hmC, which leads to passive DNA demethylation through replacing the 5hmC sites with unmethylated cytosine after rounds of DNA replication. However, whether 5hmC undergoes demethylation in non-dividing cells, for example through TDG-BER dependent active DNA demethylation, and how it may impact gene transcription and cellular properties remain elusive. To answer these questions will particularly expand our current understanding of TET catalyzed methylcytosine oxidation in the brain, the organ that has not only the highest levels of 5hmC, but also thousands of millions of non-dividing neurons that remain plastic throughout life.

Purkinje neurons in cerebellum subject to orchestrated postnatal migration, arborization, and synaptogenesis after their final cell division at mid-gestation stage. The study focuses on this neuron type and generates single base resolution 5mC and 5hmC mapping at three developmental stages (P0, P7, young adult). In addition, it profiles the Purkinje neuron specific transcriptiome (nuclei RNAseq), epigenome (H3K4me3, H3K27me3), and chromatin accessibility (ATACseq). The study therefore displays novel modes of epigenomic alterations that are associated with transcription regulation, which also confirms DNA methylation turnovers during Purkinje neuron post-mitotic maturation. Furthermore, the study generates a conditional knockout mouse line with all three TET enzymes selectively deleted in Purkinje neurons. The deficiency of TET enzymes not only impedes the DNA methylation changes during Purkinje cell postnatal maturation, but also alters neuronal excitability that increases susceptibility to an excitotoxic drug. Therefore, the study demonstrates a requirement of dynamic 5mC/5hmC changes during cerebellum Purkinje neuron post-mitotic maturation and their implication in neuronal function.

The study has successfully addressed a few technical challenges, such as the low abundancy of Purkinje neurons, to profile 5mC and 5hmC separately, and to generate a cell type specific triple TET knockout mouse line. The data are of good quality (e.g. Figure S1). Overall, the conclusions are supported by the data. Epigenetic modifications have been known to play cell type specific functions. However, the majority of current research is limited by the heterogeneity of tissue samples that lack a cell type specific resolution. To study DNA modifications in a defined neuron type, as shown in this manuscript, provides valuable novel insights (e.g. as mentioned in the Discussion, the changes are specific to Purkinje cells, but not observed in cerebellum granule neurons). In addition to sequencing 5mC and 5hmC side by side, the study also analyzes CG and CH regions separately. The study recognizes unique patterns of 5mC, 5hmC, CG and CH changes, respectively, which suggest the complexity of DNA modification in the brain. The set of genes that are associated with DNA methylation valley dynamics are particularly interesting. The genomic datasets and the mouse line derived from this study will also serve as a good resource for related work.

Through RNAseq, less than 2000 genes are found to be differentially expressed during Purkinje neuron maturation. The study therefore spends major efforts on analyzing the epigenetic changes at these genes. However, it is not sufficiently clear of the epigenetic status of the vast majority of genome beyond the differentially expressed genes, even though some indicative findings are revealed at regions with "gain" or "loss" of chromatin accessibility (Figure 2K-N). To assess this, it will be helpful to further characterize intergenic regions in the future, for example through genomic profiling of enhancer markers H3K4me1 and H3K27ac.

An enhancer marker ChIPseq is preferred, but not required. Below are some suggested revision points.

1. It will be informative to demonstrate the transcription levels of the three TET family members during Purkinje neuron maturation. This can be obtained from the RNAseq data that the authors have generated.

2. The transcriptome and epigenome differential lists should be provided in supplements.

3. It is unclear if both males and females are included in the genomic assays and animal work.

4. Though the number of cells utilized in each genomic assay is stated in methods, it will be helpful to describe the corresponding number of animals.

[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]

Thank you for resubmitting your work entitled "5-hydroxymethylcytosine mediated active demethylation is required for neuronal differentiation and function" for further consideration by eLife. Your revised article has been evaluated by Catherine Dulac (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:

Reviewer #1 (Recommendations for the authors):

In the first round of review I raised two main concerns about the molecular data – the novelty of the findings and the depth of the analysis linking Tet-mediated DNA demethylation with PC maturation. One of the other reviewers raised concerns about the physiology of the Tet cKO mice.

1. Novelty of the findings

The first concern was the degree of novelty in showing Tet-mediated DNA demethylation in post-mitotic neurons. My concern arose from the language used by the authors in their manuscript. In the abstract of the revised manuscript they state, "is it not known whether 5hmC is required for terminal differentiation or if it can serve as an intermediate in active DNA demethylation in postmitotic neurons." This assertion does not jibe with my reading of the literature. My concern was amplified when I read the sentence at line 68 in the introduction that says, "Tet mediated replication dependent passive demethylation is thought to be common in many dividing cell types, including progenitor cells in the developing forebrain (Rudenko et al. 2013), hippocampus (Guo et al. 2011) and cerebellum (Zhu et al. 2016)." This is an inaccurate statement regarding these papers from the literature.

Rudenko et al. studied DNA methylation in adult brains of a Tet1 knockout mouse and found hypermethylation of activity-regulated gene promoters in the knockout compared with wildtype. I appreciate that because this was a germline knockout that this study does not rule out the possibility that the increases in methylation occurred in dividing progenitor cells and were maintained. However, the authors of the current manuscript are over-reaching to conclude that the changes in methylation seen in the Rudenko study were indeed the result of passive demethylation in progenitors, given that this was not tested in the study. The Guo and Zhu studies knocked down Tets in postmitotic neurons. In the Guo 2011 study the authors injected shRNA-bearing AAVs targeting Tet1 in adult dentate gyrus. In the Zhu 2016 study the authors lentivirally infected primary CGN cultures with shRNAs targeting Tets 1 and 3. Both studies showed increases in DNA methylation in knockdown compared with wildtype neurons. In the Guo study this was in the context of seizure-induced demethylation of the Bdnf and Fgf1b genes, and the demethylation was blocked by Tet1 KD. Although there are a few progenitors in the adult dentate gyrus, it is not reasonable to attribute the methylation effects to only these few cells if that is what the authors mean by saying this study was in progenitors. The authors of the Guo paper concluded that Tet1 acted to actively demethylate DNA in postmitotic hippocampal neurons, and their data support that conclusion. The Zhu 2016 used primary CGNs in culture, which have been shown by many groups (using the specific protocol derived from the Hatten lab) to be fully post-mitotic within the first 24 hours after plating. shRNA-mediated knockdown occurs on the order of days (cells were studied at 3DIV). Therefore, the assumption of Guo 2016 in their conclusions that the Tets are acting to mediate these changes in post-mitotic neurons is justified.

Later (line 274) the manuscript references Lio 2016 to cite that prior studies have established that the activation of enhancers is accompanied by increased accessibility and loss of DNA methylation. At line 291 the authors suggest that the DNA demethylation they find in PCs is novel because "in this case…DNA demethylation does not require cell division." I agree it is true the PC data shows postmitotic demethylation, however it was also shown in PMID 32589877. In that study the authors purified nuclei of SST+ and VIP+ neurons from the mouse cortex during development. These experiments were done during comparing interneuron nuclei isolated at P7 with those from P13, both stages at which these neurons are already postmitotic.

These discrepancies in the manuscript between the authors' assertions of what these studies showed and the published data need to be corrected to be accurate.

It was because the authors suggested the novelty of their study as the first to show Tet-mediated active DNA demethylation in postmitotic neurons that I questioned that novelty. As the literature review above shows, this manuscript is not the first to show Tet-mediated active DNA demethylation in postmitotic neurons.

However, this manuscript does do a particularly nice job of it. I think the novelty of the study lies in linking the molecular characterization of PC chromatin regulation during development with the biology of this cell population. With this in mind, I agree with the authors that the body of the data and the analysis do make a significant new addition to the literature that will be of broad interest.

2. Depth of the analysis linking Tet-mediated DNA demethylation with PC maturation

In this revision the authors have significantly expanding and clarified the section on the molecular sequencing from Tet1/2/3 cKO mice, strengthening the impact of the data. However, even though this is a revised manuscript there are some important omissions and errors in this section that undermine the power of the data to support the model.

– Line 193, 5hmc continues to increase over highly expressed genes – where is that evidence?

– Line 202 "Furthermore, 5hmCG accumulated over the genes bodies early in development is not removed (Figure 2C)," actually what this figure shows is that for the downregulated genes there is an increase in 5hmCG over the gene bodies between P7 and adult, so it is not only not lost, it is gained. It looks no different for the downregulated genes than the upregulated genes.

– Where is the data that goes with line 372 – growth of the DMV preceded by 5hmC and starts at 5' end

– Line 376 -The text that follows this (to line 381) is entirely speculative and does not belong in the methods.

– Figure 4S2 E-G are not cited in the text.

– Line 496 – the authors state they have not seen demethylation in CGNs with no attribution and no data. Also, this contrasts with the Zhu 2016 paper so should be discussed in comparison.

Furthermore, one of the important parts of this section regards the relationship of the chromatin changes in the Tet cKO to the gene expression effects and this part would benefit from more discussion. For example, one of the best example genes for Tet mediated demethylation the authors show it Iptr and yet they specifically say this epigenomic change does not influence Iptr expression (which is key since this is the gene product used for PC isolation). Also, it is surprising that in the Tet1/2/3 cKO mice, expression of genes encoding synaptic proteins and differentiation markers are the major class elevated, not repressed. Might this suggest that the Tets actually slow differentiation rather than promoting it as the text seems to imply? Either would be interesting, but the data shown needs to be reconciled with the statement (line 106) that "maturation in Purkinje Cells … require continued oxidation of 5mC to 5hmC".

eLife. 2021 Dec 17;10:e66973. doi: 10.7554/eLife.66973.sa2

Author response


Reviewer #1 (Recommendations for the authors):

In this manuscript the authors carry out epigenomic profiling purified Purkinje cells across key stages of cerebellar development to study the regulation and function of 5hmC. The authors have previously published a method for isolation of FACS-based nuclear sorting for these cells and here they use it to isolate from P0, P7, and adult cerebellum with high quality RNA, mC/hmC, ATAC and ChIP-seq data at each time point in biological replicate. The chromatin data are correlated against developmental changes in gene expression and suggest broad mechanisms of chromatin control that are, for the most part, in line with previous studies of other cell types. The authors are particularly interested in regions of the genome that show loss of mCG (and hmCG) over developmental time and are near genes that show enhanced expression in adult PCs. They test the requirement for the Tets in the developmental demethylation of these regions by knocking out all three Tets in a PC specific manner at P7, then running RNA/mCG/hmCG sequencing in adult to compare between cTKO and control. Finally, the authors assess the functional importance of Tet-dependent gene regulation by recording from cTKO and control PCs and assessing behavioral features of PC function (rotarod and harmaline-induced tremor).

PCs are a biologically important class of neurons and they are a very different cell type from others that have been developmentally studied. For these reasons the descriptive chromatin data gathered here are of use to the community. However, the analyses performed on the data as presented here are somewhat underdeveloped. It is not clear to me that the evidence for developmental demethylation is novel and the data in Figure 4 (which could be very powerful) are not strongly deployed to argue that Tets are key in the demethylation process.

Reviewers 1 and 2 both appreciate that the data we present for transcription, DNA methylation and hydroxymethylation, chromatin accessibility, H4K4me3 and H3K27me3 histone marks are high quality and valuable for the community. We agree with this assessment, and we present them both to support our specific interests and as a resource for further analysis. With respect to our analysis being characterized as “somewhat underdeveloped”, these data are so massive that a complete study of all of their features will require many additional sets of analyses and follow up studies. There is little doubt in our minds that the data will be embraced by the community and additional biological inferences will emerge from them. Although we could populate several more figures with further analysis of these data, we have chosen to focus on only those findings supporting the most novel and important conclusions relative to the direct roles of 5hmC in differentiation.

Novelty. It has been demonstrated that the distribution of 5hmC in neuronal genomes is cell type specific and correlates with active gene expression, and that germline deletions of Tet oxidases disrupt development of the brain. Reviewer 1 is familiar with this “developmental role” of 5hmC covering the course of neuronal development – including proliferative phases of neuronal progenitor expansion where 5hmC is required for replication dependent DNA demethylation and chromatin remodeling. Replication dependent DNA demethylation is a fundamental feature of DNA methylation refinement that occurs in many cell types. However, the term “developmental demethylation” does not distinguish between the role of 5hmC mediated, replication dependent passive demethylation in progenitors and the proposed, but not proven, role of 5hmC mediated active demethylation in the absence of cell division (Ito et al., 2011). Our study was designed to arrest 5hmC formation in postmitotic differentiating PCs to address specifically this issue. The design of the study, the use of new cell type specific triple Tet1, Tet2, Tet3 triple knockout lines that activate well after the final division of PC progenitors, and the results obtained are novel and of high interest.

Figure 4. To address the remaining comments of Reviewer 1, we have edited substantially the section of the manuscript subtitled “Loss of 5mC and 5hmC in active genes during PC differentiation” presenting the data documenting loss of both 5mC and 5hmC in a specific class of highly expressed genes during PC differentiation. We believe that these new edits present the data in a concise yet very clear manner that is accessible to even a general reader. In doing so, they also augment the following section “Loss of 5mC and 5hmC in putative regulatory sites during PC differentiation”. We think this improved presentation of the data in Figure 3 establishes for the reader both that DNA demethylation occurs as PC differentiation proceeds, and that 5hmC accumulation is present in the P7 data at these sites prior to the evident loss of both 5mC and 5hmC in the adult. These new edits provide an improved introduction to Figure 4, and we believe they will help the reader understand more readily the molecular events that are disrupted as a consequence of loss of 5hmC.

Of course, to provide proof that loss of DNA methylation over the PC DMVs is dependent on 5hmC required disruption of continued 5hmC production in the Pcp2TetTKO mice. Figure 4 presents first the basic characteristics of the Pcp2TetTKO lines, establishing that their survival and body weight is normal (panels B,C), and that no gross motor phenotype is evident in rotarod performance measures (panel D). The remaining data in Figure 4 are meant to address directly the molecular events that occur in Pcp2TetTKO PCs and the requirement for 5hmC in the DNA demethylation described in Figure 3.

The description of the molecular events that occur in PCP2TetTKO PCs has been extensively lengthened to clarify each point revealed by the data. We have also changed panel G to box and whisker plots so that the reader can more easily evaluate the alterations in methylation over ATAC peaks (putative regulatory sites) that both increase in adult PCs and are associated with genes whose expression changes in the Pcp2TetTKO PCs. We hope that the additional detailed discussion of the data and our conclusions will address the comment that this section of the manuscript is “somewhat underdeveloped”.

Reviewer #2 (Recommendations for the authors):

[…] Through RNAseq, less than 2000 genes are found to be differentially expressed during Purkinje neuron maturation. The study therefore spends major efforts on analyzing the epigenetic changes at these genes. However, it is not sufficiently clear of the epigenetic status of the vast majority of genome beyond the differentially expressed genes, even though some indicative findings are revealed at regions with "gain" or "loss" of chromatin accessibility (Figure 2K-N). To assess this, it will be helpful to further characterize intergenic regions in the future, for example through genomic profiling of enhancer markers H3K4me1 and H3K27ac.

An enhancer marker ChIPseq is preferred, but not required. Below are some suggested revision points.

1. It will be informative to demonstrate the transcription levels of the three TET family members during Purkinje neuron maturation. This can be obtained from the RNAseq data that the authors have generated.

2. The transcriptome and epigenome differential lists should be provided in supplements.

3. It is unclear if both males and females are included in the genomic assays and animal work.

4. Though the number of cells utilized in each genomic assay is stated in methods, it will be helpful to describe the corresponding number of animals.

We thank Reviewer 2 for a general appreciation of our study, and we believe the new edits to the manuscript will strengthen the already positive description of our work “To study DNA modifications in a defined neuron type, as shown in this manuscript, provides valuable novel insights (e.g. as mentioned in the Discussion, the changes are specific to Purkinje cells, but not observed in cerebellum granule neurons). In addition to sequencing 5mC and 5hmC side by side, the study also analyzes CG and CH regions separately. The study recognizes unique patterns of 5mC, 5hmC, CG and CH changes, respectively, which suggest the complexity of DNA modification in the brain. The set of genes that are associated with DNA methylation valley dynamics are particularly interesting. The genomic datasets and the mouse line derived from this study will also serve as a good resource for related work.” We agree with Reviewer 2 that it “will be helpful to further characterize intergenic regions in the future, for example through genomic profiling of enhancer markers H3K4me1 and H3K27ac.” While these and many other types of experiments are certainly of interest, we view these as future studies that will continue to reveal interesting details that occur during the prolonged and complex differentiation programs characteristic of Purkinje cells and other principal neurons.

We have addressed in the revised manuscript all of the additional, detailed comments of Reviewer 2 and included additional data on the levels of expression of the Tet enzymes as PCs mature into Figure 4 Supplement 1A. Of course, the final transcriptome and epigenome lists will be provided with final manuscript. We believe these changes have improved the manuscript and thank Reviewer 2 for highlighting these issues.

[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]

Reviewer #1 (Recommendations for the authors):

In the first round of review I raised two main concerns about the molecular data – the novelty of the findings and the depth of the analysis linking Tet-mediated DNA demethylation with PC maturation.

1. Novelty of the findings

The first concern was the degree of novelty in showing Tet-mediated DNA demethylation in post-mitotic neurons. My concern arose from the language used by the authors in their manuscript. In the abstract of the revised manuscript they state, "is it not known whether 5hmC is required for terminal differentiation or if it can serve as an intermediate in active DNA demethylation in postmitotic neurons." This assertion does not jibe with my reading of the literature. My concern was amplified when I read the sentence at line 68 in the introduction that says, "Tet mediated replication dependent passive demethylation is thought to be common in many dividing cell types, including progenitor cells in the developing forebrain (Rudenko et al. 2013), hippocampus (Guo et al. 2011) and cerebellum (Zhu et al. 2016)." This is an inaccurate statement regarding these papers from the literature.

We agree with Reviewer 1 that our interpretation of these studies is rather strict. In the revised manuscript we have expanded this section to delineate the findings in each of these studies. We have added a reference n line 94 for a review of studies of 5hmC and passive demethylation in neural progenitors (MacArthur and Dawlaty, 2021). We have also included, in accord with first Reviewer’s comments, a new paragraph that explicitly states the findings of previous studies of demethylation including the mentioned references. We state that these studies provide evidence that is consistent with the hypothesis that there is active DNA demethylation in post-mitotic neurons. However, in our judgement they do not constitute definitive proof of active DNA demethylation in vivo. Consequently, this paragraph concludes with the sentence “Despite these observations, our knowledge of the roles of continued 5hmC accumulation in active DNA demethylation and postmitotic differentiation remain rudimentary. “

Rudenko et al. studied DNA methylation in adult brains of a Tet1 knockout mouse and found hypermethylation of activity-regulated gene promoters in the knockout compared with wildtype. I appreciate that because this was a germline knockout that this study does not rule out the possibility that the increases in methylation occurred in dividing progenitor cells and were maintained. However, the authors of the current manuscript are over-reaching to conclude that the changes in methylation seen in the Rudenko study were indeed the result of passive demethylation in progenitors, given that this was not tested in the study.

We agree with the Reviewer 1 that it is possible that the “hypermethylation” observed in this study results from demethylation in post-mitotic neurons. However, this is a germline KO so these changes could have occurred by passive demethylation in dividing progenitors during development. Furthermore, the assay used to assess these changes is bisulfite sequencing – it does not distinguish between 5mCG and 5hmCG. We agree with Reviewer 1 that no data are presented to directly address this issue, so we have edited the text to discuss this possibility in the revision.

The Guo and Zhu studies knocked down Tets in postmitotic neurons. In the Guo 2011 study the authors injected shRNA-bearing AAVs targeting Tet1 in adult dentate gyrus. In the Zhu 2016 study the authors lentivirally infected primary CGN cultures with shRNAs targeting Tets 1 and 3. Both studies showed increases in DNA methylation in knockdown compared with wildtype neurons. In the Guo study this was in the context of seizure-induced demethylation of the Bdnf and Fgf1b genes, and the demethylation was blocked by Tet1 KD. Although there are a few progenitors in the adult dentate gyrus, it is not reasonable to attribute the methylation effects to only these few cells if that is what the authors mean by saying this study was in progenitors. The authors of the Guo paper concluded that Tet1 acted to actively demethylate DNA in postmitotic hippocampal neurons, and their data support that conclusion.

We agree that it is possible that the increase in “methylation” observed by Guo et al. could arise by the inability to demethylate these sites. However, the assay here was again bisulfite sequencing that cannot distinguish 5mC and 5hmC. Furthermore, the protocol was to use electro convulsive stimulation to induce these changes. Since many studies have documented a strong relationship between 5hmC accumulation and transcription, since ECS causes a large increase in transcription from these promoters, and since both the Tet1 and Apobec1 knock downs leave at least Tet 2 and Tet3 activity intact, it is equally likely that the increased “methylation” seen in the KD is 5hmC rather than 5mC. Again, there are no data presented in the study to distinguish between these two possibilities. We have edited the text to clarify this issue and discuss the possibility that demethylation could occur.

The Zhu 2016 used primary CGNs in culture, which have been shown by many groups (using the specific protocol derived from the Hatten lab) to be fully post-mitotic within the first 24 hours after plating. shRNA-mediated knockdown occurs on the order of days (cells were studied at 3DIV). Therefore, the assumption of Guo 2016 in their conclusions that the Tets are acting to mediate these changes in post-mitotic neurons is justified.

The CGC cultures were prepared at P7, the time of maximal GC division in the EGL (Fujita et al. 1966, Fujita, 1967). As demonstrated by the Hatten lab (Gao et al., 1991), cell division in cultured granule cells depends on the plating density. There are no data in the paper to rule out the possibility that a subpopulation of the plated GCs divide for a day or two after being cultured. Furthermore, this paper is dedicated to showing that 5hmC is required for gene expression and does not mention demethylation.

The discussion of Figure 6 states that “5hmC levels decreased dramatically in transfected cells, while 5mC levels increased slightly. There are no statistics for this slight increase in 5mC. The word demethylation occurs only in the titles of papers cited in the References. In my opinion, this “slight increase” can’t be cited as proof of demethylation. However, we agree that this is a nice demonstration of the role of 5hmC in differentiation of granule cells and have edited the manuscript accordingly.

Later (line 274) the manuscript references Lio 2016 to cite that prior studies have established that the activation of enhancers is accompanied by increased accessibility and loss of DNA methylation. At line 291 the authors suggest that the DNA demethylation they find in PCs is novel because "in this case…DNA demethylation does not require cell division." I agree it is true the PC data shows postmitotic demethylation, however it was also shown in PMID 32589877. In that study the authors purified nuclei of SST+ and VIP+ neurons from the mouse cortex during development. These experiments were done during comparing interneuron nuclei isolated at P7 with those from P13, both stages at which these neurons are already postmitotic.

Although we thank Reviewer 1 for stimulating us to more accurately discuss the three papers cited above, we do not agree with the statement that postmitotic demethylation “was also shown in PMID 32589877”. The paper in this citation “An Activity-Mediated Transition in Transcription in Early Postnatal Neurons” (Stroud et al., Neuron, 2020) is a very nice study of enhancer activation and decommissioning in the developing brain. In the relevant section concerning the role of DNA methylation, the authors use Sst and Vip Cre drivers to knockout Dnmt3a in these interneuron types. The result is that the increase in methylation that occurs normally at these sites does not occur in the KO. The fact that there is less methylation in the KO reflects the failure of DNMT3A to methylate these sites, not DNA demethylation. The word “demethylation” does not appear in the paper. While the Stroud et al. study is very well done, it is not directly relevant and we have not cited it.

These discrepancies in the manuscript between the authors' assertions of what these studies showed and the published data need to be corrected to be accurate.

It was because the authors suggested the novelty of their study as the first to show Tet-mediated active DNA demethylation in postmitotic neurons that I questioned that novelty. As the literature review above shows, this manuscript is not the first to show Tet-mediated active DNA demethylation in postmitotic neurons.

However, this manuscript does do a particularly nice job of it. I think the novelty of the study lies in linking the molecular characterization of PC chromatin regulation during development with the biology of this cell population. With this in mind, I agree with the authors that the body of the data and the analysis do make a significant new addition to the literature that will be of broad interest.

To address these comments, we have edited the manuscript to state accurately what has been established in the literature. My strict technical interpretation of the cited papers is that the caveats discussed above prevent a definitive statement that DNA demethylation occurs in postmitotic neurons. This is the reason we went to great lengths to obtain precise data using the most advanced technology (oxBS) that can distinguish 5mC from 5hmC, and why we constructed PC specific triple knockout lines that are activated at P7 to complete this study. we understand, however, that we have been too strident and we have tried to edit the manuscript according to the comments of Reviewer 1.

2. Depth of the analysis linking Tet-mediated DNA demethylation with PC maturation

In this revision the authors have significantly expanding and clarified the section on the molecular sequencing from Tet1/2/3 cKO mice, strengthening the impact of the data. However, even though this is a revised manuscript there are some important omissions and errors in this section that undermine the power of the data to support the model.

– Line 193, 5hmc continues to increase over highly expressed genes – where is that evidence?

This is shown in Figure 2S1E. As a result of an editorial error, we did not include the figure citation in the manuscript, and the text has now been edited to correct this error.

– Line 202 "Furthermore, 5hmCG accumulated over the genes bodies early in development is not removed (Figure 2C)," actually what this figure shows is that for the downregulated genes there is an increase in 5hmCG over the gene bodies between P7 and adult, so it is not only not lost, it is gained. It looks no different for the downregulated genes than the upregulated genes.

We agree with the reviewer, and we have edited the manuscript to state that 5hmC continues to increase over these genes.

– Where is the data that goes with line 372 – growth of the DMV preceded by 5hmC and starts at 5' end

These two points are illustrated in (Figure 4H, I). In panel 4H, one can clearly see in the IGV panel that the level of 5hmC at significantly greater at P7 than in the adult over nearly the entire gene body for GPR63, and that this is also the case at the 5’end of Grid2. This is more difficult to appreciate for Grid2 because it is such a large gene and the demethylation occurs only over the first 50-100 kb of the gene. The metagene plots in Figure 4I also indicate that for this whole class of genes, the 5hmC levels are high at P7 and much less in the adult indicating that 5hmC accumulated during development is lost as the cells differentiate.

– Line 376 -The text that follows this (to line 381) is entirely speculative and does not belong in the methods.

Quote in question “These data revealed a large variation in the length of the DMV that does not form in the Pcp2TetTKO PCs. We believe this reflects a complex relationship between the timing at which transcription is initiated, the rate of transcription over the entire gene body, the local activity of Tet oxidase within the gene as differentiation proceeds, and the timing of Tet oxidase loss from each cell following recombination at the Tet1, Tet2, and Tet3 loci.

We agree with Reviewer 1 that this is speculation. The fact that the sentence starts with “We believe” clearly indicates that this is our conjecture and not a verified result. We see no reason why we can’t let the reader evaluate this idea for themselves, and we would like to leave this in the Results as it is stated.

– Figure 4S2 E-G are not cited in the text.

We made an unfortunate typo while referring to the supplemental figures. Figures 4S2 E-G were incorrectly referred to as 4S1 E-G. This has been corrected in the revision.

Furthermore, one of the important parts of this section regards the relationship of the chromatin changes in the Tet cKO to the gene expression effects and this part would benefit from more discussion. For example, one of the best example genes for Tet mediated demethylation the authors show it Iptr and yet they specifically say this epigenomic change does not influence Iptr expression (which is key since this is the gene product used for PC isolation). Also, it is surprising that in the Tet1/2/3 cKO mice, expression of genes encoding synaptic proteins and differentiation markers are the major class elevated, not repressed. Might this suggest that the Tets actually slow differentiation rather than promoting it as the text seems to imply? Either would be interesting, but the data shown needs to be reconciled with the statement (line 106) that "maturation in Purkinje Cells…..require continued oxidation of 5mC to 5hmC".

We appreciate this comment and we understand that in the simplest case one might interpret the findings as consistent with slowing differentiation. However, we don’t know whether late expressed genes in PCs may be expressed at higher levels during synaptogenesis than they are once they reach their steady state levels in the adult. We chose the word maturation to reflect this uncertainty. We have also edited the last sentence of this paragraph to state more precisely our conclusion “Taken together, our data demonstrate that active demethylation occurs in select genes in postmitotic neurons, and that 5hmC plays an essential role in refining the transcriptional and epigenetic status of Purkinje cells during the final stages of differentiation.”

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Stoyanova E, Riad M, Rao A, Heintz N. 2021. 5-hydroxymethylcytosine is required for terminal differentiation of Purkinje neurons. NCBI Gene Expression Omnibus. GSE166423

    Supplementary Materials

    Supplementary file 1. Developmental differentially expressed genes between P0 and adult Purkinje cells.
    elife-66973-supp1.xlsx (261.5KB, xlsx)
    Supplementary file 2. DNA methylation valleys (DMVs) identified in adult Purkinje neurons.
    elife-66973-supp2.xlsx (11.5KB, xlsx)
    Supplementary file 3. Differentially expressed genes in the adult triple Tet proteins knockout.
    elife-66973-supp3.xlsx (140.1KB, xlsx)
    Transparent reporting form

    Data Availability Statement

    Pcp2TetTKO mice will be made available with a Material Transfer Agreement (MTA). Sequencing data is available on NCBI Gene Expression Omnibus under accession number GSE166423. Code for data analysis is available at https://github.com/estoyanova/EStoyanova_eLife_2021 copy archived at https://archive.softwareheritage.org/swh:1:rev:4c2fa6c102e4f868fc91e0dcb0b8c7155b8f8712.

    The following dataset was generated:

    Stoyanova E, Riad M, Rao A, Heintz N. 2021. 5-hydroxymethylcytosine is required for terminal differentiation of Purkinje neurons. NCBI Gene Expression Omnibus. GSE166423


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES